The preparation and use of nucleic acid fragments encoding acyl-acyl carrier protein thioesterase enzymes to modify plant lipid composition are disclosed. Also disclosed are chimeric genes incorporating such nucleic acid fragments and suitable regulatory sequences may be used to create transgenic plants with altered levels of saturated fatty acids.
|
9. An isolated nucleic-acid fragment encoding a soybean acyl-ACP thioesterase having the amino acid sequence of SEQ ID NO:29.
11. An isolated nucleic-acid fragment encoding a rapeseed acyl-ACP thioesterase having the amino acid sequence of SEQ ID NO:32.
10. An isolated nucleic-acid fragment encoding a rapeseed acyl-ACP thioesterase having the amino acid sequence of SEQ ID NO:30.
3. An isolated nucleic acid fragment encoding the canola seed acyl-ACP thioesterase encoded by nucleotides 1 to 1483 of SEQ ID NO:2.
4. An isolated nucleic acid fragment encoding the canola seed acyl-ACP thioesterase encoded by nucleotides 1 to 1674 of SEQ ID NO:31.
2. An isolated nucleic acid fragment encoding the soybean seed acyl-ACP thioesterase encoded by nucleotides 1 to 1688 of SEQ ID NO:1.
1. An isolated nucleic acid fragment encoding a plant acyl-ACP thioesterase wherein said thioesterase has a preference of at least two-fold for palmitoyl-ACP over either stearoyl-ACP or oleoyl-ACP and farther wherein said isolated nucleic acid fragment hybridizes to one of the nucleotide sequences set forth in SEQ ID NOS:1, 2, and 31 under the following set of conditions: hybridization at 60°C in 6×SCC, 0.1% SDS for 18 hr, washing at 60°C in 0.2×SSC, 0.1% SDS twice for 10 min each.
5. An isolated nucleic acid fragment encoding a plant acyl-ACP thioesterase wherein said thioesterase has a preference of at least two-fold for palmitoyl-ACP over either stearoyl-ACP or oleoyl-ACP and further wherein said isolated nucleic acid fragment hybridizes to nucleotides 506 to 1477 of SEQ ID NO:1, nucleotides 255 to 1226 of SEQ ID NO:2, or nucleotides 479 to 1438 of SEQ ID NO:31 under the following set of conditions: hybridization at 60°C in 6×SCC, 0.1% SDS for 18 hr, washing at 60°C in 0.2×SSC, 0.1% SDS twice for 10 min each.
6. The isolated nucleic acid fragment of
7. The isolated nucleic acid fragment of
8. The isolated nucleic acid fragment of
12. A chimeric gene for transforming a plant of an oil producing species comprising the nucleic acid fragment of
13. A chimeric gene for transforming a plant of an oil producing species comprising the nucleic acid fragment of
14. A chimeric gene for transforming a plant of an oil producing species comprising the nucleic acid fragment of
15. A chimeric gene for transforming a plant of an oil producing species comprising the nucleic acid fragment of
16. A chimeric gene for transforming a plant of an oil producing species comprising the nucleic acid fragment of
17. A chimeric gene for transforming a plant of an oil producing species comprising the nucleic acid fragment of
18. The chimeric gene of
19. The chimeric gene of
22. The plant cell, as described in
23. The plant cell, as described in
24. A method of producing plant seed oil comprising lower-than-normal levels of palmitic and stearic acids comprising:
(a) transforming plant cells of an oil producing species with the chimeric gene of (b) growing fertile plants from the transformed plant cells obtained from step (a), (c) screening progeny seeds from said fertile plants for lower-than-normal levels palmitic and stearic acids, and (d) crushing said progeny seeds to obtain said plant seed oil comprising lower-than-normal levels of palmitic and stearic acids.
25. A method of producing plant seed oil comprising higher-than-normal levels of palmitic and stearic acids comprising:
(a) transforming plant cells of an oil producing species with the chimeric gene of (b) growing fertile plants from the transformed plant cells obtained from step (a), (c) screening progeny seeds from said fertile plants for higher-than-normal levels of palmitic and stearic acids, and (d) crushing said progeny seeds to obtain said plant seed oil comprising higher-than-normal levels of palmitic and stearic acids.
26. A method of producing soybean seed oil comprising lower-than-normal levels of palmitic and stearic acids comprising:
(a) transforming soybean cells with the chimeric gene of (b) growing fertile soybean plants from the transformed soybean cells obtained from step (a), (c) screening progeny seeds from said fertile soybean plants for lower-than-normal levels of palmitic and stearic acids, and (d) crushing said progeny seeds to obtain said soybean seed oil comprising lower-than-normal levels of palmitic and stearic acids.
27. A method of producing soybean seed oil comprising higher-than-normal levels of palmitic and stearic acids comprising:
(a) transforming soybean cells with the chimeric gene of (b) growing fertile soybean plants from the transformed soybean cells obtained from step (a), (c) screening progeny seeds from said fertile soybean plants for higher-than-normal levels of palmitic and stearic acids, and (d) crushing said progeny seeds to obtain said soybean seed oil comprising higher-than-normal levels of palmitic and stearic acids.
28. A method of producing rapeseed seed oil comprising lower-than-normal levels of palmitic and stearic acids comprising:
(a) transforming rapeseed cells with the chimeric gene of (b) growing fertile rapeseed plants from the transformed rapeseed cells obtained from step (a), (c) screening progeny seeds from said fertile rapeseed plants for lower-than-normal levels of palmitic and stearic acids, and (d) crushing said progeny seeds to obtain said rapeseed seed oil comprising lower-than-normal levels of palmitic and stearic acids.
29. A method of producing rapeseed seed oil comprising higher-than-normal levels of palmitic and stearic acids comprising:
(a) transforming rapeseed cells with the chimeric gene of (b) growing fertile rapeseed plants from the transformed rapeseed cells obtained from step (a), (c) screening progeny seeds from said fertile rapeseed plants for higher-than-normal levels of palmitic and stearic acids, and (d) crushing said progeny seeds to obtain said rapeseed seed oil comprising higher-than-normal levels of palmitic and stearic acids.
30. The method of
31. The method of
32. The method of
33. The method of
34. A method of producing rapeseed seed oil comprising lower-than-normal levels of palmitic and stearic acids comprising:
(a) transforming rapeseed cells with the chimeric gene of (b) growing fertile rapeseed plants from the transformed rapeseed cells obtained from step (a), (c) screening progeny seeds from said fertile rapeseed plants for lower-than-normal levels of palmitic and stearic acids, and (d) crushing said progeny seeds to obtain said rapeseed seed oil comprising lower-than-normal levels of palmitic and stearic acids.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This application is a 371 of PCT/US95/10627 filed Aug. 25, 1995 which is a continuation of U.S. application Ser. No. 08/299,044, filed Aug. 31, 1994, now abandoned.
The invention relates to the preparation and use of nucleic acid fragments encoding acyl-acyl carrier protein thioesterase enzymes to modify plant lipid composition. Chimeric genes incorporating such nucleic acid fragments and suitable regulatory sequences may be used to create transgenic plants with altered levels of saturated fatty acids.
Plant lipids have a variety of industrial and nutritional uses and are central to plant membrane function and climatic adaptation. These lipids represent a vast array of chemical structures, and these structures determine the physiological and industrial properties of the lipid. Many of these structures result either directly or indirectly from metabolic processes that alter the degree of saturation of the lipid.
Plant lipids find their major use as edible oils in the form of triacylglycerols. The specific performance and health attributes of edible oils are determined largely by their fatty acid composition. Most vegetable oils derived from commercial plant varieties are composed primarily of palmitic (16:0), stearic (18:0), oleic (18:1), linoleic (18:2) and linolenic (18:3) acids. Palmitic and stearic acids are, respectively, 16 and 18carbon-long, saturated fatty acids. Oleic, linoleic, and linolenic acids are 18-carbon-long, unsaturated fatty acids containing one, two, and three double bonds, respectively. Oleic acid is referred to as a mono-unsaturated fatty acid, while linoleic and linolenic acids are referred to as poly-unsaturated fatty acids. The relative amounts of saturated and unsaturated fatty acids in commonly used, edible vegetable oils are summarized below (Table 1):
| TABLE 1 |
| Percentages of Saturated and Unsaturated Fatty |
| Acids in the Oils of Selected Oil Crops |
| Saturated Mono-unsaturated Poly-unsaturated |
| Canola 6% 58% 36% |
| Soybean 15% 24% 61% |
| Corn 13% 25% 62% |
| Peanut 18% 48% 34% |
| Safflower 9% 13% 78% |
| Sunflower 9% 41% 51% |
| Cotton 30% 19% 52% |
Many recent research efforts have examined the role that saturated and unsaturated fatty acids play in reducing the risk of coronary heart disease. In the past, it was believed that mono-unsaturates, in contrast to saturates and poly-unsaturates, had no effect on serum cholesterol and coronary heart disease risk. Several recent human clinical studies suggest that diets high in mono-unsaturated fat and low in saturated fat may reduce the "bad" (low-density lipoprotein) cholesterol while maintaining the "good" (high-density lipoprotein) cholesterol (Mattson et al., Journal of Lipid Research (1985) 26:194-202). Soybean oil is high in saturated fatty acids when compared to other sources of vegetable oil and contains a low proportion of oleic acid, relative to the total fatty acid content of the soybean seed. These characteristics do not meet important health needs as defined by the American Heart Association.
A soybean oil low in total saturates and polyunsaturates and high in monounsaturate would provide significant health benefits to the United States population, as well as, economic benefit to oil processors.
Oil biosynthesis in plants has been fairly well-studied [see Harwood (1989) in Critical Reviews in Plant Sciences, Vol. 8 (1):1-43]. The biosynthesis of palmitic, stearic and oleic acids occur in the plastids by the interplay of three key enzymes of the "ACP track": palmitoyl-ACP elongase, stearoyl-ACP desaturase and the acyl-ACP thioesterases.
Of these three enzyme types, the acyl-ACP thioesterases function to remove the acyl chain from the carrier protein (ACP) and thus from the metabolic pathway. The oleoy-ACP thioesterase catalyzes the hydrolysis of oleoyl-ACP thioesters at high rates and at much lower rates the hydrolysis of palmitoyl-ACP and stearoyl-ACP. This multiple activity leads to substrate competition between enzymes and it is the competition of this acyl-ACP thioesterase and palmitoyl-ACP elongase for the same substrate and of acyl-ACP thioesterase and stearoyl-ACP desaturase for the same substrate that leads to a portion of the production of the palmitic and stearic acids found in the triacylglyceride of vegetable oils.
Once removed from the ACP track fatty acids are exported to the cytoplasm and there used to synthesize acyl-coenzyme A. These acyl-CoA's are the acyl donors for at least three different glycerol acylating enzymes (glycerol-3-P acyltransferase, 1-acyl-glycerol-3-P acyltransferase and diacylglycerol acyltransferase) which incorporate the acyl moieties into triacylglycerides during oil biosynthesis.
These acyltransferases show a strong, but not absolute, preference for incorporating saturated fatty acids at positions 1 and 3 and monounsaturated fatty acid at position 2 of the triglyceride. Thus, altering the fatty acid composition of the acyl pool will drive by mass action a corresponding change in the fatty acid composition of the oil.
Based on the above discussion, one approach to altering the levels of palmitic, stearic and oleic acids in vegetable oils is by altering their levels in the cytoplasmic acyl-CoA pool used for oil biosynthesis.
In previous work (WO 9211373) Applicant has demonstrated that oleoyl-ACP thioesterase may be modulated using cloned cDNA encoding the soybean enzyme. Oleoyl-ACP thioesterase cDNA was used to form chimeric genes for the transformation of soybean plant cells resulting in the anti-sense inhibition of acyl-ACP thioesterase in the plant seed.
Applicant has now discovered an entirely new plant thioesterase with activity on a C16 substrate that is also useful for the regulation of the acyl coenzyme A pool. Applicant has isolated nucleic acid fragments that encode soybean and canola palmitoyl-ACP thioesterases that are useful in modifying fatty acid composition in oil-producing species by genetic transformation. Thus, transfer of the nucleic acid fragments of the invention or a part thereof that encodes a functional enzyme, along with suitable regulatory sequences that direct the transcription of their mRNA, into a living cell will result in the production or over-production of palmitoyl-ACP thioesterases and will result in increased levels of saturated fatty acids in cellular lipids, including triacylglycerols.
Transfer of the nucleic acid fragments of the invention or a part thereof, along with suitable regulatory sequences that direct the transcription of their anti-sense RNA, into plants will result in the inhibition of expression of the endogenous palmitoyl-ACP thioesterase that is substantially homologous with the transferred nucleic acid fragment and will result in decreased levels of saturated fatty acids in cellular lipids, including triacylglycerols.
Transfer of the nucleic acid fragments of the invention or a part thereof, along with suitable regulatory sequences that direct the transcription of their mRNA, into plants may result in inhibition by cosuppression of the expression of the endogenous palmitoyl-ACP thioesterase gene that is substantially homologous with the transferred nucleic acid fragment and may result in decreased levels of unsaturated fatty acids in cellular lipids, including triacylglycerols.
A means to control the levels of saturated and unsaturated fatty acids in edible plant oils has been discovered. Utilizing the soybean seed palmitoyl-ACP thioesterase cDNA, for either the precursor or enzyme, chimeric genes are created and may be utilized to transform soybean plants to produce seed oils with reduced levels of saturated fatty acids. Similarly the canola seed palmitoyl-ACP thioesterase cDNA for either the precursor or enzyme may be utilized to create chimeric genes and these genes may then be used to transform canola plants to produce seed oils with reduced levels of saturated fatty acids.
Specifically, one aspect of the present invention is a nucleic acid fragment comprising a nucleotide sequence encoding the soybean seed palmitoyl-ACP thioesterase cDNA corresponding to nucleotides 1 to 1688 in the sequence shown in Sequence Description SEQ ID NO:1, or any nucleic acid fragment substantially homologous therewith. In addition, another aspect involves a nucleic acid fragment comprising a nucleotide sequence encoding the canola seed palmitoyl-ACP thioesterase cDNA corresponding to the nucleotides 1 to 1488 in the Sequence Description SEQ ID NO:2, nucleotides 1 to 1674 in the Sequence Description SEQ ID NO:31 or any nucleic acid fragment substantially homologous therewith. Preferred are those nucleic acid fragments encoding the soybean seed palmitoyl-ACP thioesterase precursor, the mature soybean seed palmitoyl-ACP thioesterase enzyme, the canola seed palmitoyl-ACP thioesterase precursor, and the mature canola seed palmitoyl-ACP thioesterase enzyme.
Another aspect of this invention involves a chimeric gene capable of transforming a soybean plant cell comprising a nucleic acid fragment encoding the soybean seed palmitoyl-ACP thioesterase cDNA of Sequence ID 1 operably linked to suitable regulatory sequences producing anti-sense inhibition of soybean seed palmitoyl-ACP thioesterase in the seed or linked suitably to produce sense expression of the soybean seed palmitoyl-ACP thioesterase gene resulting in either over expression of the palmitoyl-ACP thioesterase protein or under expression of the palmitoyl-ACP thioesterase protein when co-suppression occurs. Preferred are those chimeric genes which incorporate nucleic acid fragments encoding soybean seed palmitoyl-ACP thioesterase precursor or mature soybean seed palmitoyl-ACP thioesterase enzyme.
Yet another embodiment of the invention involves a method of producing seed oil containing either elevated or reduced levels of saturated fatly acids comprising; (a) transforming a soybean plant cell with a chimeric gene described above, (b) growing sexually mature plants from said transformed plant cells, (c) screening progeny seeds from said sexually mature plants for the desired levels of palmitic and stearic acid, and (d) crushing said progeny seed to obtain said oil containing decreased levels of palmitic and stearic acid. Preferred methods of transforming such plant cells would include the use of Ti and Ri plasmids of Agrobacterium, electroporation, and high-velocity ballistic bombardment.
Another aspect of this invention involves a chimeric gene capable of transforming a canola plant cell comprising a nucleic acid fragment encoding the canola seed palmitoyl-ACP thioesterase cDNA of Sequence ID 2 or Sequence ID 31 operably linked to suitable regulatory sequences producing anti-sense inhibition of canola seed palmitoyl-ACP thioesterase in the seed or linked suitably to produce sense expression of the canola seed palmitoyl-ACP thioesterase gene resulting in either over expression of the palmitoyl-ACP thioesterase protein or under expression of the palmitoyl-ACP thioesterase protein when co-suppression occurs. Preferred are those chimeric genes which incorporate nucleic acid fragments encoding canola seed palmitoyl-ACP thioesterase precursor or mature canola seed palmitoyl-ACP thioesterase enzyme.
The invention can be more fully understood from the following detailed description and the Sequence Descriptions which form a part of this application.
The sequence descriptions summarize the Sequences Listing attached hereto. The Sequence Listing contains one letter codes for nucleotide sequence characters and the three letter codes for amino acids as defined in the IUPAC-IUB standards described in Nucleic Acids Research 13:3021-3030 (1985) and in the Biochemical Journal 219 (No. 2):345-373 (1984), and the symbols and format used for all nucleotide and amino acid sequence data further comply with the rules governing nucleotide and/or amino acid sequence disclosures in patent applications as set forth in 37 C.F.R. §1.821-1.825.
SEQ ID NO:1 sets forth the nucleotide sequence of a soybean palmitoyl-ACP thioesterase cDNA.
SEQ ID NO:2 sets forth the nucleotide sequence of a canola palmitoyl-ACP thioesterase cDNA.
SEQ ID NOS:3 and 4 set forth the sequence of oligonucleotides used to form a linker.
SEQ ID NO:5 sets forth the sequence of an oligonucleotide primer derived from SEQ ID NO: 1.
SEQ ID NO:6 sets forth the deduced sequence of the protein expressed in E. coli from the canola cDNA set forth in SEQ ID NO:2.
SEQ ID NO:7 is the deduced sequence of the protein expressed in E. coli from the soybean cDNA set forth in SEQ ID NO:1.
SEQ ID NO:8 sets forth the nucleotide sequence of the napin promoter used to drive seed-specific expression of thioesterase in canola.
SEQ ID NO:9 sets forth the complement of the sequence of SEQ ID NO:8.
SEQ ID NO:10 sets forth the sequence derived from the napin gene 3' of the coding region.
SEQ ID NO: 11 sets forth the complement of the sequence of SEQ ID NO:10.
SEQ ID NO:12 sets forth the sequence of an oligonucleotide primer derived from SEQ ID NO:1.
SEQ ID NOS:13 through 20 set forth the sequences of oligonucleotide primers used to amplify segments of the napin promoter.
SEQ ID NOS:21 and 22 set forth the sequences of oligonucleotide primers used to amplify segments of the napin terminator region.
SEQ ID NOS:23 and 24 set forth the sequences of oligonucleotide primers used to amplify a segment from the 3' end of the napin promoter.
SEQ ID NOS:25 and 26 set forth short sequences of DNA that were introduced into the PCR amplified version of the napin terminator.
SEQ ID NO:27 sets forth the reverse complement of the soybean cDNA sequence of SEQ ID NO:1.
SEQ ID NO:28 sets forth the reverse complement of the canola cDNA sequence of SEQ ID NO:2.
SEQ ID NO:29 sets forth the predicted amino acid sequence encoded by the sequence of SEQ ID NO:1.
SEQ ID NO:30 sets forth the predicted amino acid sequence encoded by the sequence of SEQ ID NO:2.
SEQ ID NO:31 sets forth the nucleotide sequence of a second canola palmitoyl-ACP thioesterase cDNA.
SEQ ID NO:32 sets forth the predicted amino acid sequence encoded by the sequence of SEQ ID NO:31.
In the context of this disclosure, a number of terms shall be used.
Fatty acids are specified by the number of carbon atoms and the number and position of the double bond: the numbers before and after the colon refer to the chain length and the number of double bonds, respectively. The number following the fatty acid designation indicates the position of the double bond from the carboxyl end of the fatty acid with the "c" affix for the cis-configuration of the double bond. For example, palmitic acid (16:0), stearic acid (18:0), oleic acid (18:1,9c), petroselinic acid (18:1, 6c), linoleic acid (18:2, 9c,12c), g-linolenic acid (18:3, 6c,9c,12c) and a-linolenic acid (18:3, 9c,12c,15c). Unless otherwise specified 18:1, 18:2 and 18:3 refer to oleic, linoleic and linolenic fatty acids. The term "palmitoyl-ACP thioesterase" used herein refers to an enzyme which catalyzes the hydrolytic cleavage of the carbon-sulfur thioester bond in the pantothene prosthetic group of palmitoyl-acyl carrier protein as its preferred reaction. Hydrolysis of other fatty acid-acyl carrier protein thioesters may also be catalyzed by the enzymes. The term "nucleic acid" refers to a large molecule which can be single-stranded or double-stranded, composed of monomers (nucleotides) containing a sugar, a phosphate and either a purine or pyrimidine. A "nucleic acid fragment" is a fraction of a given nucleic acid molecule. In higher plants, deoxyribonucleic acid (DNA) is the genetic material while ribonucleic acid (RNA) is involved in the transfer of the information in DNA into proteins. A "genome" is the entire body of genetic material contained in each cell of an organism. The term "nucleotide sequence" refers to the sequence of DNA or RNA polymers, which can be single- or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases capable of incorporation into DNA or RNA polymers. The term "oligomer" refers to short nucleotide sequences, usually up to 100 bases long. As used herein, the term "homologous to" refers to the relatedness between the nucleotide sequence of two nucleic acid molecules or between the amino acid sequences of two protein molecules. Estimates of such homology are provided by either DNA-DNA or DNA-RNA hybridization under conditions of stringency as is well understood by those skilled in the art (Hames and Higgins, Eds. (1985) Nucleic Acid Hybridisation, IRL Press, Oxford, U.K.); or by the comparison of sequence similarity between two nucleic acids or proteins, such as by the method of Needleman et al. (J. Mol. Biol. (1970) 48:443-453). As used herein, "substantially homologous" refers to nucleotide sequences that have more than 90% overall identity at the nucleotide level with the coding region of the claimed sequence, such as genes and pseudo-genes corresponding to the coding regions. The nucleic acid fragments described herein include molecules which comprise possible variations, both man-made and natural, such as but not limited to (a) those that involve base changes that do not cause a change in an encoded amino acid, or (b) which involve base changes that alter an amino acid but do not affect the functional properties of the protein encoded by the DNA sequence, (c) those derived from deletions, rearrangements, amplifications, random or controlled mutagenesis of the nucleic acid fragment, and (d) even occasional nucleotide sequencing errors.
"Gene" refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding) and following (3' non-coding) the coding region. "Native" gene refers to an isolated gene with its own regulatory sequences as found in nature. "Chimeric gene" refers to a gene that comprises heterogeneous regulatory and coding sequences not found in nature. "Endogenous" gene refers to the native gene normally found in its natural location in the genome and is not isolated. A "foreign" gene refers to a gene not normally found in the host organism but that is introduced by gene transfer. "Pseudo-gene" refers to a genomic nucleotide sequence that does not encode a functional enzyme.
"Coding sequence" refers to a DNA sequence that codes for a specific protein and excludes the non-coding sequences. It may constitute an "uninterrupted coding sequence", i.e., lacking an intron or it may include one or more introns bounded by appropriate splice junctions. An "intron" is a nucleotide sequence that is transcribed in the primary transcript but that is removed through cleavage and re-ligation of the RNA within the cell to create the mature mRNA that can be translated into a protein.
"Initiation codon" and "termination codon" refer to a unit of three adjacent nucleotides in a coding sequence that specifies initiation and chain termination, respectively, of protein synthesis (mRNA translation). "Open reading frame" refers to the coding sequence uninterrupted by introns between initiation and termination codons that encodes an amino acid sequence.
"RNA transcript" refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing of the primary transcript and is referred to as the mature RNA. "Messenger RNA (mRNA)" refers to the RNA that is without introns and that can be translated into protein by the cell. "cDNA" refers to a double-stranded DNA that is complementary to and derived from mRNA. "Sense" RNA refers to RNA transcript that includes the mRNA. "Antisense RNA" refers to a RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene by interfering with the processing, transport and/or translation of its primary transcript or mRNA. The complementarity of an antisense RNA may be with any part of the specific gene transcript, i.e., at the 5' non-coding sequence, 3' non-coding sequence, introns, or the coding sequence. In addition, as used herein, antisense RNA may contain regions of ribozyme sequences that increase the efficacy of antisense RNA to block gene expression. "Ribozyme" refers to a catalytic RNA and includes sequence-specific endoribonucleases.
As used herein, "suitable regulatory sequences" refer to nucleotide sequences in native or chimeric genes that are located upstream (5'), within, and/or downstream (3') to the nucleic acid fragments of the invention, which control the expression of the nucleic acid fragments of the invention. The term "expression", as used herein, refers to the transcription and stable accumulation of the sense (mRNA) or the antisense RNA derived from the nucleic acid fragment(s) of the invention that, in conjunction with the protein apparatus of the cell, results in altered levels of the palmitoyl-ACP thioesterase. Expression or overexpression of the gene involves transcription of the gene and translation of the mRNA into precursor or mature palmitoyl-ACP thioesteras proteins. "Antisense inhibition" refers to the production of antisense RNA transcripts capable of preventing the expression of the target protein. "Overexpression" refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms. "Cosuppression" refers to the expression of a foreign gene which has substantial homology to an endogenous gene resulting in the suppression of expression of both the foreign and the endogenous gene. "Altered levels" refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non-transformed organisms.
"Promoter" refers to a DNA sequence in a gene, usually upstream (5') to its coding sequence, which controls the expression of the coding sequence by providing the recognition for RNA polymerase and other factors required for proper transcription. In artificial DNA constructs promoters can also be used to transcribe antisense RNA. Promoters may also contain DNA sequences that are involved in the binding of protein factors which control the effectiveness of transcription initiation in response to physiological or developmental conditions. It may also contain enhancer elements. An "enhancer" is a DNA sequence which can stimulate promoter activity. It may be an innate element of the promoter or a heterologous element inserted to enhance the level and/or tissue-specificity of a promoter. "Constitutive promoters" refers to those that direct gene expression in all tissues and at all times. "Tissue-specific" or "development-specific" promoters as referred to herein are those that direct gene expression almost exclusively in specific tissues, such as leaves or seeds, or at specific development stages in a tissue, such as in early or late embryogenesis, respectively.
The "3' non-coding sequences" refers to the DNA sequence portion of a gene that contains a poly-adenylation signal and any other regulatory signal capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor.
"Transformation" herein refers to the transfer of a foreign gene into the genome of a host organism and its genetically stable inheritance. "Restriction fragment length polymorphism" refers to different sized restriction fragment lengths due to altered nucleotide sequences in or around variant forms of genes. "Fertile" refers to plants that are able to propagate sexually.
"Plants" refer to photosynthetic organisms, both eukaryotic and prokaryotic, whereas the term "Higher plants" refers to eukaryotic plants. "Oil-producing species" herein refers to plant species which produce and store triacylglycerol in specific organs, primarily in seeds. Such species include soybean (Glycine max), rapeseed and canola (including Brassica napus, B. campestris), sunflower (Helianthus annus), cotton (Gossypium hirsutum), corn (Zea mays), cocoa (Theobroma cacao), safflower (Carthamus tinctorius), oil palm (Elaeis guineensis), coconut palm (Cocos nucifera), flax (Linum usitatissimum), castor (Ricinus communis) and peanut (Arachis hypogaea). The group also includes non-agronomic species which are useful in developing appropriate expression vectors such as tobacco, rapid cycling Brassica species, and Arabidopsis thaliana, and wild species which may be a source of unique fatty acids.
"Sequence-dependent protocols" refer to techniques that rely on a nucleotide sequence for their utility. Examples of sequence-dependent protocols include, but are not limited to, the methods of nucleic acid and oligomer hybridization and methods of DNA and RNA amplification such as are exemplified in various uses of the polymerase chain reaction (PCR).
"PCR" or "polymerase chain reaction" will refer to a method that results in the linear or logarithmic amplification of nucleic acid molecules. PCR generally requires a replication composition consisting of, for example, nucleotide triphosphates, two primers with appropriate sequences, DNA or RNA polymerase and proteins. These reagents and details describing procedures for their use in amplifying nucleic acids are provided in U.S. Pat. No. 4,683,202 (1987, Mullis, et al.) and U.S. Pat. No. 4,683,195 (1986, Mullis, et al.).
The present invention describes two nucleic acid fragments that encode soybean and canola seed palmitoyl-ACP thioesterases. These enzymes catalyze the hydrolytic cleavings of palmitic acid, stearic acid and oleic acid from ACP in the respective acyl-ACPs. Transfer of one or both of these nucleic acid fragments of the invention or a part thereof that encodes a functional enzyme, with suitable regulatory sequences into a living cell will result in the production or over-production of palmitoly-ACP thioesterase, which may result in increased levels of palmitic and to a lesser extent, stearic acids in cellular lipids, including oil.
Transfer of the nucleic acid fragment or fragments of the invention, with suitable regulatory sequences that transcribe the present cDNA, into a plant which has an endogenous seed palmitoyl-ACP thioesterase that is substantially homogeneous with the present cDNA may result in inhibition by co-suppresion of the expression of the endogenous palmitoyl-ACP thioesterase gene and, consequently, in a decreased amount of palmitic and to a lesser extent stearic acids in the seed oil.
Transfer of the nucleic acid fragment or fragments of the invention into a soybean or canola plants with suitable regulatory sequences that transcribe the anti-sense RNA complementary to the mRNA, or its precursor, for seed palmitoyl-ACP thioesterase may result in the inhibition of the expression of the endogenous palmitoyl-ACP thioesterase gene and, consequently, in reduced amounts of palmitic and to a lesser extent stearic acids in the seed oil.
The nucleic acid fragments of the invention can also be used as a restriction fragment length polymorphism markers in soybean and canola genetic studies and breeding programs.
In order to identify cDNA encoding for palmitoyl-ACP thioesterase in both soybean and canola it was first necessary to construct a probe suitable for screening cDNA libraries from these plant genomes. A portion of the Arabidopis cDNA known to have significant homology with an Umbellularia C12:0-ACP thioesterase was used to design PCR primers (SEQ ID NO:3 and 4). Polysomal RNA was isolated and purified from Arabidopis and used as a template for RNA-PCR (GeneAmp® PNA-PCR kit Perkin Elmer Cetus, part number N808-0017). Using this method a 560 bp fragment was generated, and radiolabeled to be used as a probe for screening soybean and canola cDNA libraries.
Methods of creating cDNA libraries from eukaryotic genomes are well known in the art (see, for example, Sambrook, et al. (Molecular Cloning, A Laboratory Manual, 2nd ed. (1989), Cold Spring Harbor Laboratory Press). In a preferred method total RNA is isolated (Kamalay et al., (Cell (1980) 19:935-946) and polyadenylated mRNA is purified by standard means. mRNA is incorporated into a suitable phage such as lambda phage and used to transform a suitable host such as E. coli. Transformed clones are screened for positively hybridizing plaques using the radio-labelled, PCR derived probe.
In this manner DNA fragments were selected from both soybean and canola that had potential for encoding an acyl-ACP thioesterase. The DNA fragment isolated from soybean is identified as SEQ ID NO:1 and the DNA fragments isolated from canola are identified as SEQ ID NO:2 and SEQ ID NO:31.
In order to verify the function of the isolated soybean and canola DNA fragments it was necessary to express the fragments in recombinant hosts for protein purification and analysis of enzyme activity.
The present invention provides vectors and host cells suitable for genetic manipulations and the expression of recombinant proteins. Suitable hosts may include a variety of gram negative and gram positive bacteria where E. coli is generally preferred. Examples of bacteria-derived vectors include plasmid vectors such as pBR322, pUC19, pSP64, pUR278 and pORF1. Illustrative of suitable viral vectors are those derived from phage, vaccinia, and a variety of viruses. Examples of phage vectors include 1+, 1EMBL3, 12001, 1gt10, 1gt11, Charon 4a, Charon 40, and 1ZAP/R. pXB3 and pSC11 are exemplary of vaccinia vectors (Chakrabarti et al., Molec. Cell. Biol. 5:3401-9 (1985) and Mackett et al. J. Virol. 49:857864 (1984). Preferred in the present invention are the bacteria derived vectors such as pET-3d (described by F. W. Studier, A. H. Rosenberg, J. J. Dunn and J. W. Dubendorff, Methods in Enzymology Vol. 185) and the host E. coli strain BL21(DE3)(pLysE).
Once suitable vectors are constructed they are used to transform suitable bacterial hosts. Introduction of desired DNA fragments into E. coli may be accomplished by known procedures such as by transformation, e.g., using calcium-permeabilized cells, electroporation, or by transfection using a recombinant phage virus (Sambrook et al., supra.)
For the expression of the soybean and canola DNA fragments (SEQ ID NO:1 and 2, respectively) the fragments were first cut with the appropriate restriction enzymes for the isolation of the region encoding the mature protein. Following this the restriction fragments were ligated to an appropriate linker sequence and inserted into a suitable vector downstream of an appropriate promoter. Suitable promoters may be either inducible or constitutive and are preferably derived from bacteria. Examples of suitable promoters are 17 and lac.
Methods for the measurement of thioesterase activity are known in the art (see, for example, Smith et al., Biochem, J. 212, 155, (1983) and Spencer et al., J. Biol. Chem., 253, 5922, (1978)). For the purpose of the present invention a modification of the method of Mckeon and Stumpf [J. Biol. Chem. (1982) 257:12141-12147] was used involving the synthesis of radiolabelled substrate ([14 C]acyl-ACP) using ACP and ACP synthetase isolated from E. coli. Solutions of [14 C] palmitic acid, [14 C] stearic acid, [14 C] oleic acid, [14 C] lauric acid, and [14 C] decanoic acid were added to purified ACP in the presence of ACP synthetase and the resulting radiolabelled acyl ACP was purified by standard methods. Activity of the protein encoded and expressed by SEQ ID NO:1 and SEQ ID NO:2 was measured on the basis of the amount of [14 C] substrate that was hydrolyzed.
Antisense RNA has been used to inhibit plant target genes in a tissue-specific manner (see van der Krol et al., Biotechniques (1988) 6:958-976). Antisense inhibition has been shown using the entire cDNA sequence (Sheehy et al., Proc. Natl. Acad. Sci. USA (1988) 85:8805-8809) as well as a partial cDNA sequence (Cannon et al., Plant Molec. Biol. (1990) 15:39-47). There is also evidence that the 3' non-coding sequences (Ch'ng et al., Proc. Natl. Acad. Sci. USA (1989) 86:10006-10010) and fragments of 5' coding sequence, containing as few as 41 base-pairs of a 1.87 kb cDNA (Cannon et al., Plant Molec. Biol. (1990) 15:39-47), can play important roles in anti-sense inhibition.
The entire soybean palmitoyl-ACP thioesterase cDNA was cloned in the anti-sense orientation with respect to a soybean β-conglycinin promoter and the chimeric gene transformed into soybean somatic embryos. As demonstrated in Example 2, these embryos serve as good model system for soybean zygotic embryos. Transformed somatic embryos showed inhibition of palmitate and possibly stearate biosyntheis. Similarly, the entire Brassica napus palmitoyl-ACP cDNA was cloned in the anti-sense orientation with respect to a rapeseed napin promoter and the chimeric gene transformed into B. napus.
The phenomenon of cosuppression has also been used to inhibit plant target genes in a tissue-specific manner. Cosuppression of an endogenous gene using the entire cDNA sequence (Napoli et al., The Plant Cell (1990) 2:279-289; van der Krol et al., The Plant Cell (1990) 2:291-299) as well as a partial cDNA sequence (730 bp of a 1770 bp cDNA) (Smith et al., Mol. Gen. Genetics (1990) 224:477-481) are known.
The nucleic acid fragments of the instant invention encoding palmitoyl-ACP thioesterases or parts thereof, with suitable regulatory sequences, can be used to reduce the level of palmitoyl-ACP thioesterase, thereby altering fatty acid composition, in transgenic plants which contain an endogenous gene substantially homologous to the introduced nucleic acid fragment. The experimental procedures necessary for this are similar to those described above for the anti-sense expression of palmitoyl-ACP thioesterase nucleic acid fragments except that one may use a either whole or partial cDNA.
Endogenous genes can also be inhibited by non-coding regions of an introduced copy of the gene [for example, Brusslan, J. A., et al. (1993) Plant Cell 5:667-677; Matzke, M. A. et al Plant Molecular Biology 16:821-830].
A preferred class of heterologous hosts for the expression of the nucleic acid fragments of the invention are eukaryotic hosts, particularly the cells of higher plants. Particularly preferred among the higher plants are the oil-producing species, such as soybean (Glycine max), rapeseed (including Brassica napus, B. campestris), sunflower (Helianthus annus), cotton (Gossypium hirsutum), corn (Zea mays), cocoa (Theobroma cacao), safflower (Carthamus tinctorius), oil palm (Elaeis guineensis), coconut palm (Cocos nucifera), flax (Linum usitatissimum), and peanut (Arachis hypogaea).
Expression in plants will use regulatory sequences functional in such plants. The expression of foreign genes in plants is well-established (De Blaere et al., Meth. Enzymol. (1987) 153:277-291). The source of the promoter chosen to drive the expression of the fragments of the invention is not critical provided it has sufficient transcriptional activity to accomplish the invention by increasing or decreasing, respectively, the level of translatable mRNA for the fatty acid desaturases in the desired host tissue. Preferred promoters include (a) strong constitutive plant promoters, such as those directing the 19S and 35S transcripts in cauliflower mosaic virus (Odell et al., Nature (1985) 313:810-812; Hull et al., Virology (1987) 86:482-493), (b) tissue- or developmentally-specific promoters, and (c) other transcriptional promoter systems engineered in plants, such as those using bacteriophage T7 RNA polymerase promoter sequences to express foreign genes. Examples of tissue-specific promoters are the light-inducible promoter of the small subunit of ribulose 1,5-bis-phosphate carboxylase (if expression is desired in photosynthetic tissues), the maize zein protein promoter (Matzke et al., EMBO J. (1984) 3:1525-1532), and the chlorophyll a/b binding protein promoter (Lampa et al., Nature (1986) 316:750-752).
Particularly preferred promoters are those that allow seed-specific expression. This may be especially useful since seeds are the primary source of vegetable oils and also since seed-specific expression will avoid any potential deleterious effect in non-seed tissues. Examples of seed-specific promoters include, but are not limited to, the promoters of seed storage proteins, which can represent up to 90% of total seed protein in many plants. The seed storage proteins are strictly regulated, being expressed almost exclusively in seeds in a highly tissue-specific and stage-specific manner (Higgins et al., Ann. Rev. Plant Physiol. (1984) 35:191-221; Goldberg et al., Cell (1989) 56:149-160). Moreover, different seed storage proteins may be expressed at different stages of seed development.
Expression of seed-specific genes has been studied in great detail (see reviews by Goldberg et al., Cell (1989) 56:149-160 and Higgins et al., Ann. Rev. Plant Physiol. (1984) 35:191-221). There are currently numerous examples of seed-specific expression of seed storage protein genes in transgenic dicotyledonous plants. These include genes from dicotyledonous plants for bean b-phaseolin (Sengupta-Gopalan et al., Proc. Natl. Acad, Sci. USA (1985) 82:3320-3324; Hoffman et al., Plant Mol. Biol. (1988) 11:717-729), bean lectin (Voelker et al., EMBO J. (1987) 6:3571-3577), soybean lectin (Okamuro et al., Proc. Natl. Acad. Sci. USA (1986) 83:8240-8244), soybean Kunitz trypsin inhibitor (Perez-Grau et al., Plant Cell (1989) 1:095-1109), soybean b-conglycinin (Beachy et al., EMBO J. (1985) 4:3047-3053; pea vicilin (Higgins et al., Plant Mol. Biol. (1988) 11:683-695), pea convicilin (Newbigin et al., Planta (1990) 180:461-470), pea legumin (Shirsat et al., Mol. Gen. Genetics (1989) 215:326-331); rapeseed napin (Radke et al., Theor. Appl. Genet. (1988) 75:685-694) as well as genes from monocotyledonous plants such as for maize 15 kD zein (Hoffman et al., EMBO J. (1987) 6:3213-3221), maize 18 kD oleosin (Lee et al., Proc Natl. Acad. Sci. USA (1991) 888:6181-6185), barley b-hordein (Marris et al., Plant Mol. Biol. (1988) 10:359-366) and wheat glutenin (Colot et al., EMBO J. (1987) 6:3559-3564). Moreover, promoters of seed-specific genes operably linked to heterologous coding sequences in chimeric gene constructs also maintain their temporal and spatial expression pattern in transgenic plants. Such examples include use of Arabidopsis thaliana 2S seed storage protein gene promoter to express enkephalin peptides in Arabidopsis and B. napus seeds (Vandekerckhove et al., Bio/Technology (1989) 7:929-932), bean lectin and bean b-phaseolin promoters to express luciferase (Riggs et al., Plant Sci. (1989) 63:47-57), and wheat glutenin promoters to express chloramphenicol acetyl transferase (Colot et al., EMBO J. (1987) 6:3559-3564).
Of particular use in the expression of the nucleic acid fragment of the invention will be the heterologous promoters from several soybean seed storage protein genes such as those for the Kunitz trypsin inhibitor (Jofuku et al., Plant Cell (1989) 1:1079-1093; glycinin (Nielson et al., Plant Cell (1989) 1:313-328), and b-conglycinin (Harada et al., Plant Cell (1989) 1:415-425). Promoters of genes for a- and b-subunits of soybean b-conglycinin storage protein will be particularly useful in expressing the mRNA or the antisense RNA in the cotyledons at mid- to late-stages of seed development (Beachy et al., EMBO J. (1985) 4:3047-3053) in transgenic plants. This is because there is very little position effect on their expression in transgenic seeds, and the two promoters show different temporal regulation. The promoter for the a-subunit gene is expressed a few days before that for the b-subunit gene. This is important for transforming rapeseed where oil biosynthesis begins about a week before seed storage protein synthesis (Murphy et al., J. Plant Physiol. (1989) 135:63-69).
Also of particular use will be promoters of genes expressed during early embryogenesis and oil biosynthesis. The native regulatory sequences, including the native promoters, of the palmitoyl-ACP thioesterase genes expressing the nucleic acid fragments of the invention can be used following their isolation by those skilled in the art. Heterologous promoters from other genes involved in seed oil biosynthesis, such as those for B. napus isocitrate lyase and malate synthase (Comai et al., Plant Cell (1989) 1:293-300), delta-9 desaturase from safflower (Thompson et al. Proc. Natl. Acad. Sci. USA (1991) 88:2578-2582) and castor (Shanklin et al., Proc. Natl. Acad. Sci. USA (1991) 88:2510-2514), acyl carrier protein (ACP) from Arabidopsis (Post-Beittenmiller et al., Nucl. Acids Res. (1989) 17:1777), B. napus (Safford et al., Eur. J. Biochem. (1988) 174:287-295), and B. campestris (Rose et al., Nucl. Acids Res. 1987) 15:7197), b-ketoacyl-ACP synthetase from barley (Siggaard-Andersen et al., Proc. Natl. Acad. Sci. USA (1991) 88:4114-4118), and olcosin from Zea mays (Lee et al., Proc. Natl. Acad. Sci. USA (1991) 88:6181-6185), soybean (Genbank Accession No: X60773) and B. napus (Lee et al., Plant Physiol. (1991) 96:1395-1397) will be of use. If the sequence of the corresponding genes is not disclosed or their promoter region is not identified, one skilled in the art can use the published sequence to isolate the corresponding gene and a fragment thereof containing the promoter. The partial protein sequences for the relatively-abundant enoyl-ACP reductase and acetyl-CoA carboxylase are also published (Slabas et al., Biochim. Biophys. Acta (1987) 877:271-280; Cottingham et al., Biochim. Biophys. Acta (1988) 954:201-207) and one skilled in the art can use these sequences to isolate the corresponding seed genes with their promoters. Attaining the proper level of expression of the nucleic acid fragments of the invention may require the use of different chimeric genes utilizing different promoters. Such chimeric genes can be transferred into host plants either together in a single expression vector or sequentially using more than one vector.
It is envisioned that the introduction of enhancers or enhancer-like elements into the promoter regions of either the native or chimeric nucleic acid fragments of the invention will result in increased expression to accomplish the invention. This would include viral enhancers such as that found in the 35S promoter (Odell et al., Plant Mol. Biol. (1988) 10:263-272), enhancers from the opine genes (Fromm et al., Plant Cell (1989) 1:977-984), or enhancers from any other source that result in increased transcription when placed into a promoter operably linked to the nucleic acid fragment of the invention.
Of particular importance is the DNA sequence element isolated from the gene for the a-subunit of b-conglycinin that can confer 40-fold seed-specific enhancement to a constitutive promoter (Chen et al., Dev. Genet. (1989) 10:112-122). One skilled in the art can readily isolate this element and insert it within the promoter region of any gene in order to obtain seed-specific enhanced expression with the promoter in transgenic plants. Insertion of such an element in any seed-specific gene that is expressed at different times than the b-conglycinin gene will result in expression in transgenic plants for a longer period during seed development.
Any 3' non-coding region capable of providing a polyadenylation signal and other regulatory sequences that may be required for the proper expression of the nucleic acid fragments of the invention can be used to accomplish the invention. This would include 3' ends of the native fatty acid desaturase(s), viral genes such as from the 35S or the 19S cauliflower mosaic virus transcripts, from the opine synthesis genes, ribulose 1,5-bisphosphate carboxylase, or chlorophyll a/b binding protein. There are numerous examples in the art that teach the usefulness of different 3' non-coding regions.
Various methods of transforming cells of higher plants according to the present invention are available to those skilled in the art (see EPO Pub. 0 295 959 A2 and 0 318 341 A1). Such methods include those based on transformation vectors utilizing the Ti and Ri plasmids of Agrobacterium spp. It is particularly preferred to use the binary type of these vectors. Ti-derived vectors transform a wide variety of higher plants, including monocotyledonous and dicotyledonous plants (Sukhapinda et al., Plant Mol. Biol. (1987) 8:209-216; Potrykus, Mol. Gen. Genet. (1985) 199:183). Other transformation methods are available to those skilled in the art, such as direct uptake of foreign DNA constructs (see EPO Pub. 0 295 959 A2), techniques of electroporation (Fromm et al., Nature (1986) (London) 319:791) or high-velocity ballistic bombardment with metal particles coated with the nucleic acid constructs (Kline et al., Nature (1987) (London) 327:70). Once transformed, the cells can be regenerated by those skilled in the art.
Of particular relevance are the recently described methods to transform foreign genes into commercially important crops, such as rapeseed (De Block et al., Plant Physiol. (1989) 91:694-701), sunflower (Everett et al., Bio/Technology (1987) 5:1201), and soybean (Christou et al., Proc. Natl. Acad. Sci USA (1989) 86:7500-7504.
The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.
PAC MATERIALS AND METHODSVarious solutions used in the experimental manipulations are referred to by their common names such as "SSC", "SSPE", "Denhardt's solution", etc. The composition of these solutions as well as any method for the standard manipulation of nucleic acids, transformatins and growth of E. coli may be found by reference to Sambrook, et al. (Molecular Cloning, A Laboratory Manual, 2nd ed. (1989), Cold Spring Harbor Laboratory Press)
Growth Media:
Media for the growth of plant embryo cultures is given below:
TBL Plant Embryo Culture Media Media: SB55 and SBF6 Stock Solutions (g/L): MS Sulfate 100X Stock MgSO4 7H2 O 37.0 MnSO4 H2 O 1.69 ZaSO4 7H2 O 0.86 CuSO4 5H2 O 0.0025 MS Halides 100X Stock CaCl2 2H2 O 44.0 KI' 0.083 CoCl2 6H2 O 0.00125 KH2 PO4 17.0 H3 BO3 0.62 Na2 MoO4 2H2 O 0.025 MS FeEDTA 100X Stock Na2 EDTA 3.724 FeSO4 7H2 O 2.784 B5 Vitamin Stock 10 g m-inositol 100 mg nicotinic acid 100 mg pyridaxine HCl 1 g thiamine SB55 (per Liter) 10 mL each MS stocks 1 mL B5 Vitamin stock 0.8 g NH4 NO3 5 3.033 g KNO3 1 mL 2,4-D (10 mg (mL stock) 60 g sucrose 0.667 g asparagine pH 5.7 For SBP6-substitute 0.5 mL 2,4-D 10 SB103 (per Liter) MS Salts 6% maltose 750 mg MgCl2 0.2% Gelrite 15 pH 5.7 SB71-1 (per liter) B5 salts 1 mL B5 vitamin stock 3% sucrose 750 mg MgCl2 20 0.2% gelrite pH 5.7Media for the transformation of Brassica Napus cells and the growth of agrobacterium described in Example 4 is as follows:
Dissolve in distilled water:
10.5 grams potassium phosphate, dibasic
4.5 grams potassium phosphate, monobasic
1.0 gram ammonium sulfate
0.5 gram sodium citrate, dihydrate
Make up to 979 mL with distilled water
Autoclave
Add 20 mL filter-sterilized 10% sucrose
Add 1 mL filter-sterilized 1 M MgSO4
Per liter: 40
Murashige and Skoog Minimal Organic Medium (MS salts, 100 mg/L i-inositol, 0.4 mg/L thiamine; GIBCO #510-3118)
30 grams sucrose
18 grams mannitol
1.0 mg/L 2,4-D
0.3 mg/L kinetin
0.6% agarose
pH 5.8
Murashige and Skoog Minimal Organic Medium
Gamborg B5 Vitamins (SIGMA #1019)
10 grams glucose
250 mg xylose
600 mg MES
0.4% agarose
pH 5.7
Filter-sterilize and add after autoclaving:
2.0 mg/L zeatin
0.1 mg/L IAA
Murashige and Skoog Minimal Organic Medium
Gamborg B5 Vitamins
10 grams sucrose
0.6% agarose
pH 5.8
To assay for the presence of thioesterase activity [14 C] radiolabled acyl ACP substrates were prepared. Preparation of the substrates required the isolation of ACP and ACP synthetase from E. coli and the enzymatic reaction of [14 C] fatty acid with the ACP protein.
To frozen E. coli cell paste, (0.5 kg of 1/2 log phase growth of E. coli B grown on minimal media and obtained from Grain Processing Corp, Muscatine, Iowa.) was added 50 mL of a solution 1M in Tris, 1M in glycine, and 0.25 M in EDTA. Ten mL of 1M MgCl2 was added and the suspension was thawed in a water bath at 50°C As the suspension approached 37° C. it was transferred to a 37°C bath, made to 10 mM in 2-mercaptoethanol and 20 mg of DNAse and 50 mg of lysozyme were added. The suspension was stirred for 2 h, then sheared by three 20 second bursts in a Waring Blendor. The volume was adjusted to 1 L and the mixture was centrifuged at 24,000×g for 30 min. The resultant supernatant was centrifuged at 90,000×g for 2 h. The resultant high-speed pellet was saved for extraction of acyl-ACP synthase (see below) and the supernatant was adjusted to pH 6.1 by the addition of acetic acid. The extract was then made to 50% in 2-propanol by the slow addition of cold 2-propanol to the stirred solution at 0°C The resulting precipitate was allowed to settle for 2 h and then removed by centrifugation at 16,000×g. The resultant supernatant was adjusted to pH 6.8 with KOH and applied at 2 mL/min to a 4.4×12 cm column of DEAE-Sephacel which had been equilibrated in 10 mM MES, pH 6.8. The column was washed with 10 mM MES, pH 6.8 and eluted with 1 L of a gradient of LiCl from 0 to 1.7M in the same buffer. Twenty mL fractions were collected and the location of eluted ACP was determined by applying 10 μL of every second fraction to a lane of a native polyacrylamide (20% acrylamide) gel electrophoresis (PAGE). Fractions eluting at about 0.7M LiCl contained nearly pure ACP and were combined, dialyzed overnight against water and then lyophilized.
Membrane pellets resulting from the high-speed centrifugation described above were homogenized in 380 mL of 50 mM Tris-Cl pH 8.0, and 0.5 M in NaCl and then centrifuged at 80,000×g for 90 min. The resultant supernatant was discarded and the pellets resuspended in 50 mM Tris-Cl, pH 8.0, to a protein concentration of 12 mg/mL. The membrane suspension was made to 2% in Triton X-100 and 10 mM in MgCl2, and stirred at 0°C for 20 min before centrifugation at 80,000×g for 90 min. The protein in the resultant supernatant was diluted to 5 mg/mL with 2% Triton X-100 in 50 mM Tris-Cl, pH 8.0 and, then, made to 5 mM ATP by the addition of solid ATP (disodium salt) along with an equimolar amount of NaHCO3. The solution was warmed in a 55°C bath until the internal temperature reached 53°C and was then maintained at between 53°C and 55°C for 5 min. After 5 min the solution was rapidly cooled on ice and centrifuged at 15,000×g for 15 min. The supernatant from the heat treatment step was loaded directly onto a column of 7 mL Blue Sepharose 4B which had been equilibrated in 50 mM Tris-Cl, pH 8.0, and 2% Triton X-100. The column was washed with 5 volumes of the loading buffer, then 5 volumes of 0.6 M NaCl in the same buffer and the activity was eluted with 0.5 M KSCN in the same buffer. Active fractions were assayed for the synthesis of acyl-ACP, as described below, combined, and bound to 3 mL settled-volume of hydroxlyapatite equilibrated in 50 mM Tris-Cl, pH 8.0, 2% Triton X-100. The hydroxylapatite was collected by centrifugation, washed twice with 20 mL of 50 mM Tris-Cl, pH 8.0, 2% Triton X-100. The activity was eluted with two 5 mL washes of 0.5 M potassium phosphate, pH 75, 2% Triton X-100. The first wash contained 66% of the activity and it was concentrated with a 30 kD membrane filtration concentrator (Amicon) to 1.5 mL.
A solutions of [14 C] palmitic acid, [14 C] stearic acid, [14 C] oleic acid, [14 C] lauric acid, and [14 C] decanoic acid (120 nmoles each) prepared in methanol were dried in glass reaction vials. The ACP preparation described above (1.15 mL, 32 nmoles) was added along with 0.1 mL of 0.1 M ATP, 0.05 mL of 80 mM DTT, 0.1 mL of 8 M LiCl, and 0.2 mL of 13% Triton X-100 in 0.5 M Tris-Cl, pH 8.0, with 0.1 M MgCl2. The reaction was mixed thoroughly and 0.3 mL of the acyl-ACP synthase preparation was added and the reaction was incubated at 37°C After one-half h intervals a 10 μL aliquot was taken and dried on a small filter paper disc. The disc was washed extensively with chloroform:methanol:acetic acid (8:2:1, v:v:v) and radioactivity retained on the disc was taken as a measure of [14 C]- acyl-ACP. At 2 h about 88% of the ACP had been consumed. The reaction mixes were diluted 1 to 4 with 20 mM Tris-Cl, pH 8.0, and applied to 1 mL DEAE-Sephacel columns equilibrated in the same buffer. The columns were washed in sequence with 5 mL of 20 mM Tris Cl, pH 8.0, 5 mL of 80% 2-propanol in 20 mM Tris-Cl, pH 8.0, and eluted with 0.5 M LiCl in 20 mM Tris-Cl, pH 8∅ The column eluates were passed directly onto 3 mL columns of octyl-sepharose CL-4B which were washed with 10 mL of 20 mM potassium phosphate, pH 6.8, and then fluted with 35% 2-propanol in 2 mM potassium phosphate, pH 6.8. The eluted products were lyophilized and redissolved at a concentration of 24 μM.
PAC ISOLATION OF CDNA'S FOR SOYBEAN AND CANOLA SEED PALMITOYL-ACP THIOESTERASEPCR Synthesis of a DNA Probe for an Arabidopsis cDNA with Sequence Homology to a Medium Chain Fatty acyl-ACP Thioesterase
A portion of the sequence of an Arabidopsis cDNA sequenced in the Arabidopsis thaliana transcribed genome sequencing project (clone YAP140T7) obtained from Genbank entry Z17678 (Arabidopsis thaliana systematic cDNA sequencing reveals a gene with homology with Umbellularia californica C12:0-ACP thioesterase (Francoise et al., Plant Physiol. Biochem. 31, 599, (1993)) and additional sequence from an Arabidopis thaliana cDNA clone obtained using that sequence and communicated by Dr. John Ohrolgge (Michigan State University) were used to make two PCR primers shown in SEQ ID NO:3 (the 5' extending primer) and SEQ ID NO:4 (the 3' extending primer). Total RNA was extracted from green seliques of Arabidopis plants and polysomal RNA was isolated following the procedure of Kamalay et al., (Cell (1980) 19:935-946). The polyadenylated mRNA fraction was obtained by affinity chromatography on oligo-dT cellulose (Aviv et al., Proc. Natl. Acad. Sci. USA (1972) 69:1408-1411). Thirteen ng of the polyadenylated mRNA was used as template for amplification from oligo-dT using a GeneAmp® RNA-PCR kit (Perkin Elmer Cetus, part number N808-0017). PCR was done at an annealing temperature of 52°C for 35 cycles. A DNA fragment of about 560 base pairs was generated and isolated by agarose gel purification.
The isolated fragment was used as the template for random primer labeling with [32 P]dCTP.
The radiolabelled probe was used to screen a Brassica napus seed cDNA library. In order to construct the library, Brassica napus seeds were harvested 20-21 days after pollination, placed in liquid nitrogen, and polysomal RNA was isolated following the procedure of Kamalay et al., (Cell (1980) 19:935-946). The polyadenylated mRNA fraction was obtained by affinity chromatography on oligo-dT cellulose (Aviv et al., supra). Four micrograms of this mRNA were used to construct a seed cDNA library in lambda phage (Uni-ZAP_XR vector) using the protocol described in the ZAP-cDNA--. Synthesis Kit (1991 Stratagene Catalog, Item #200400). Approximately 240,000 clones were screened for positively hybridizing plaques using the radiolabelled, PCR derived probe described above essentially as described in Sambrook et al., supra except that low stringency hybridization conditions (50 mM Tris, pH 7.6, 6×SSC, 5×Denhardt's, 0.5% SDS, 100 μg denatured calf thymus DNA and 50°C) were used and post-hybridization washes were performed twice with 2×SSC, 0.5% SDS at room temperature for 15 min, then twice with 0.2×SSC, 0.5% SDS at room temperature for 15 min, and then twice with 0.2×SSC, 0.5% SDS at 50°C for 15 min. Nine positive plaques showing strong hybridization were picked, plated out, and the screening procedure was repeated. From the secondary screen four, pure phage plagues were isolated. Plasmid clones containing the cDNA inserts were obtained through the use of a helper phage according to the in vivo excision protocol provided by Stratagene. Double-stranded DNA was prepared using the Magic® Miniprep (Promega) and the manufacturers instructions, and the resulting plasmids were size-analyzed by electrophoresis in agarose gels. One of the four clones, designated p5a, contained an approximately 1.5 kb insert which was sequenced from both strands by the di-deoxy method. The sequence of 1483 bases of the cDNA insert of p5a is shown in SEQ ID NO:2. A second clone, designated p2a was also sequenced and found to contain a 1673 base pair cDNA shown in SEQ ID NO31. The sequences of the two cDNA inserts arc 85% identical overall, they encode peptides that are 92% identical overall but which are 94% identical within the region of the putative mature peptide (the peptide after removal of the plastid transit sequence). The cDNA regions of the two cDNAs which encode the mature peptides are 90.4% identical. The two cDNAs probably encode two isozymes of the same activity. Based on the length of the transit peptides for the two sequences the length of the respective cDNAs and alignments to the soybean sequences shown below, it appears that the cDNA in clone p5a is a slightly truncated version of the actual message while clone p2a represents a full length message. The cDNA isolated from clone p2a has been sequenced and the sequence is given in SEQ ID NO 31. Cloning of a Soybean Seed cDNA Homologus to the Arabidopis Thioesterase Like Fragment
A cDNA library was made as follows: Soybean embryos (ca. 50 mg fresh weight each) were removed from the pods and frozen in liquid nitrogen. The frozen embryos were ground to a fine powder in the presence of liquid nitrogen and then extracted by Polytron homogenization and fractionated to enrich for total RNA by the method of Chirgwin et al. (Biochemistry (1979) 18:5294-5299). The nucleic acid fraction was enriched for poly A+ RNA by passing total RNA through an oligo-dT cellulose column and eluting the poly A+ RNA with salt as described by Goodman et al. (Meth. Enzymol. (1979) 68:75-90) cDNA was synthesized from the purified poly A+ RNA using cDNA Synthesis System (Bethesda Research Laboratory) and the manufacturer's instructions. The resultant double-stranded DNA was methylated by Eco RI DNA methylase (Promega) prior to filling-in its ends with T4 DNA polymerase (Bethesda Research Laboratory) and blunt-end ligation to phosphorylated Eco RI linkers using T4 DNA ligase (Pharmacia, Upsalla Sweden). The double-stranded DNA was digested with Eco RI enzyme, separated from excess linkers by passage through a gel filtration column (Sepharose CL-4B), and ligated to lambda ZAP vector (Stratagene, 1109 N. Torrey Pine Rd., LaJolla Calif.) according to manufacturer's instructions. Ligated DNA was packaged into phage using the Gigapack packaging extract (Stratagene) according to manufacturer's instructions. The resultant cDNA library was amplified as per Stratagene's instructions and stored at -80°C
Following the instructions in the Lambda ZAP Cloning Kit Manual (Stratagene), the cDNA phage library was used to infect E. coli BB4 cells and a total of approximately 360,000 plaque forming units were plated onto 6, 150 mm diameter petri plates. Duplicate lifts of the plates were made onto nitrocellulose filters (Schleicher & Schuell). The filters were prehybridized in 25 mL of hybridization buffer consisting of 6×SSPE, 5×Denhardt's solution, 0.5% SDS, 5% dextran sulfate and 0.1 mg/mL denatured salmon sperm DNA (Sigma Chemical Co.) at 50°C for 2 h. Radiolabelled probe based on the Arabidopsis PCR product described above was added, and allowed to hybridize for 18 h at 50°C The filters were washed exactly as described above. Autoradiography of the filters indicated that there were 9 strongly hybridizing plaques. The 9 plaques were subjected to a second round of screening as before.
From the secondary screen three, pure phage plaques were isolated. Plasmid clones containing the cDNA inserts were obtained through the use of a helper phage according to the in vivo excision protocol provided by Stratagene. Double-stranded DNA was prepared using the Magic® Miniprep (Promega) and the manufacturers instructions, and the resulting plasmids were size-analyzed by electrophoresis in agarose gels. One of the four clones, designated p233b, contained an approximately 1.2 kb insert one strand of which was partially sequenced by the di-deoxy method. The 311 bases of p233b that were sequenced showed a sequence identity of 81.2% in comparison to the Arabidopsis thioesterase like sequence which was the basis for the PCR probe. The other two clones isolated from the inital screening appeared to be cDNA concatomers in which the primary inserts were of a size similar to p233a. Comparison of the sequence at the 5 prime end of p233a to both the canola sequence and the Arabidopsis sequence indicated that p233a is a 5 prime truncated version of the putative thioesterase. The cDNA insert of p233b was removed by digestion with Eco RI and the insert was purified by agarose gel electrophoresis. The purified insert was used as the template for random primer labeling as described above. Approximately 150,000 plaque forming units of the soybean seed cDNA library were plated on three plates as described above and duplicate nitrocellulose lifts were screened at high stringency (hybridization at 60°C in 6×SCC, 0.1% SDS for 18 hr, washing at 60°C in 0.2×SSC, 0.1% SDS twice for 10 min each). Of 18 positive plaques obtained, one designated pTE11, and containing a 1.5 kB insert was chosen for sequencing by the di-deoxy method. The sequence of the 1688 bases in the soybean cDNA insert of pTE11 are shown in SEQ ID 1.
PAC EXPRESSION OF THE CATALYTICALLY ACTIVE PROTEIN ENCODED BY THE SOYBEAN AND CANOLA cDNA'S HOMOLOGUS TO THE PUTATIVE THIOESTERASE FROM ARABIDOPSIS IN E. COLIPlasmid vectors for the expression of the portions of the soybean and canola putative thioesterase cDNA's assumed to encode the pro-protein were made using the vector pET-3d (described by F. W. Studier, A. H. Rosenberg, J. J. Dunn and J. W. Dubendorff, Methods in Enzymology Vol. 185) and the host cell strain BL21(DE3)(pLysE).
The canola clone p5a was digested with Pvu II and Hin DIII to release a 1235 base pair fragment which was blunted with DNA polymerase I before isolation by agarose gel electrophoresis. Two oligonucletides were synthesisized which, when annealed together form the following linker sequence:
5'-CATGGAGGAGCAG (SEQ ID NO:3)
3'-CTCCTCGTC (SEQ ID NO:4)
The linkers were ligated to the 1235 base pair fragment which was then ligated into the Nco I digested and calf intestinal phosphatase treated pET-3d. The ligation mixture was used to transform competent BL21(DE3)(pLyE) cells and twenty ampicillin resistant clonies were used to inocculate 5 mL liquid cultures. Plasmid DNA was prepared from the cultures and digested with Pvu II, Nco I and Eco RI to determine the presence of an insert and its orientation with respect to the T7 promoter. Only one insert containing plasmid was obtained, and the orientation of the conding region with respect to the promoter was reversed. The plasmid DNA was digested with Nco I, the insert isolated and religated into Nco I digested, phosphatase treated pET-3d as above. The ligation mixture was used to transform competent XL-1 cells. Ten isolated colonies were used to inocculate 5 mL liquid cultures and plasmid DNA was isolated. Three clones were determined to be in the forward direction by their Eco RI restriction fragment pattern. The region across the cloning site was sequenced and found to place the start methionine encoded by the linker DNA sequence in frame with the protein encoded by the canola cDNA to give the deduce amino acid sequence shown in SEQ ID NO:6.
The soybean cDNA containing plamid pTE11 was digested with Sph I and Eco RI, blunted with DNA polymerase I and the resulting 1208 base pair fragment was isolated by agarose gel electrophoresis. The above described linkers were ligated to the fragment and the product was ligated into the pET-3b vector as described for the canola cDNA fragment above. The ligation mixture was used to transform competent XL-1 cells and ten of the colonies obtained were used to inocculate 5 mL liquid cultures. Plasmid DNA isolated from the cultures was digested with Nco I to determine the presence of a cDNA insert and with Hpa I and Sph I to determine the orientation of the insert relative to the 17 promoter. One clone with a correctly oriented insert was obtained and used to transform competent BL21(DE3)(pLysE) cells. The deduced amino acid sequence of the expressed protein is shown in SEQ ID NO:7.
Single colonies of the BL21(DE3)(pLysE) strains containing the pET: canola and the soybean cDNA expression vectors were used to inocculate 5 mL of 2×YT media containing 50 mg/L ampicilin. The cultures were grown overnight at 37°C, diluted to 0.1 OD at 600 nm with fresh, ampicillin containing media and re-grown to 1.5 OD at 600 nm at 37° C. Both cultures were induced by the addition of IPTG to a final concentration of 1 mM. Cells were harvested by centrifugation three hr after induction. A volume of lysis buffer (50 mM HEPES, pH 7.5, 15 mM NaCl, 0.5 mM EDTA, 1 mM DTT and 15% glycerol) approximately equal to the pellet volume was added and the cell were resuspended by vortex mixing. A small amount of 2 mm glass beads and 0.2 M PMSF in 2-propanol to a final concentration of 0.2 mM was added just before sonication. The cell lysate was centrifuged in a microfuge to clear and the supernatent of the canola cDNA expressing cell line was diluted one to twenty with 50 mM Tricine (pH 8.2, 1 mg/mL BSA and 1 mM DTT) to give a lysate protein concentration of 1.8 mg/mL. The cell line expressing the soybean cDNA was similarly diluted one to five to give a lysate protein concentration of 2.4 mg/mL.
Reagents and substrates for the thioesterase assay are prepared as described above in the the MATERIALS AND METHODS section. Acyl-ACP thioesterase was assayed as described by Mckeon and Stumpf [J. Biol. Chem. (1982) 257:12141-121471]. Each of the radiolabeled acyl-ACP's were adjusted to concentrations ranging from 0.18 μM to 2.06 μM and a volume of 40 μL with a reaction buffer consisting of 1 mg/mL bovine serum albumin in CAPS-NaOH buffer (50 mM) at pH 9.5. Reactions were started with lysate from E. coli expressing the plant cDNA's for the putative acyl-ACP thioesterase from either soybean seed or canola seed and incubated for times varying from 12 seconds to 1 min depending upon the activity of the fraction. Reactions were terminated by the addition of 100 μl of a solution of 5% acetic acid in 2-propanol and extracted twice with 1 mL each of water saturated hexane. Five mL of ScintiVerse Bio HP (Fisher) scintillation fluid was added to the combined extracts and radioactivity in the released fatty acids was determined by scintilation counting.
Thioesterase assays done on E. coli extracts from cultures which were not transformed with thioesterase expressing plasmids had specific activities of about 0.025 nmole/min/mg protein in the palmitoyl-ACP, stearoyl-ACP and oleoyl-ACP assays when the assay was done at 1 μM substrate concentration. Since this E. coli background was from 70 to 150 fold less than the activity found in the plant thioesterase expressing lines, it is ignored in the following data.
Assays were done at 4 substrate concentrations for the soybean enzyme and at a concentration which gave maximal activity for the canola enzyme. Assays were done such that less than 25% of the available substrate was consumed at each substrate concentration and the substrate concentration listed in Table 2 is the average concentration during the time of the reaction.
| TABLE 2 |
| Activity of the Soybean and Canola Thioesterases |
| Against Palmitolv-ACP, Steroyl-ACP and Oleoyl-ACP |
| SPECIFIC ACTIVITY |
| SUBSTRATE (nmole/min/mg protein) |
| Soybean Thiosterase |
| Palmitoyl-ACP |
| 0.18 μM 1.17 |
| 0.37 μM 1.87 |
| 0.74 μM 3.43 |
| 1.01 μM 3.61 |
| Stearoyl-ACP |
| 0.18 μM 0.67 |
| 0.41 μM 1.08 |
| 0.81 μM 1.80 |
| 1.62 μM 1.76 |
| Oleoyl-ACP |
| 0.18 μM 0.21 |
| 0.41 μM 0.77 |
| 1.03 μM 0.86 |
| 2.06 μM 0.98 |
| Palmitoyl-ACP* |
| 0.58 μM 17.6 |
| Docecanoly-ACP* |
| 0.54 μM 0.11 |
| Lauroyl-ACP* |
| 0.54 μM 0.07 |
| Canola Thioesterase |
| Palmitoyl-ACP |
| 1.01 μM 3.33 |
| Stearoyl-ACP |
| 0.81 μM 1.27 |
| Oleoyl-ACP |
| 1.03 μM 1.76 |
| *Data from a separate experiment in which the pET:soybean palmitolyl |
| thioesterase was expressed to a higher level in BL21 (DE3) cells. |
The data in Table 2 shows that both the canola and the soybean enzymes are acyl-ACP thioesterases. While neither enzyme has significant activity toward lauroyl-ACP or decanoly-ACP which is the substrate for the enzyme that they were initially idenified as homologus to (Arabidopsis thaliana systematic cDNA sequencing reveals a gene with homology with Umbellularia californica C12:0-ACP thioesterase. Francoise Grellet, Richard Cooke, Monique Raynal, Michele Laudie and Michel Delseny, Plant Physiol. Biochem. 1993 31:599-602), both are active against longer acyl chain-ACP's. Both have a preference of between two and three fold for palmitoyl-ACP over either stearoyl-ACP or oleoyl-ACP. This is in contrast to the known acyl-ACP thioesterases from these species which show a strong substrate preference for oleoyl-ACP [WO 9211373]. The enzymes thus represent a second class of acyl-ACP thioesterase, present within the same tissues as the oleoyl-ACP thioesterase which have substrate preference for long chain, saturated acyl-ACP's.
PAC REGULATION OF THE EXPRESSION OF PALMITOYL-ACP THIOESTERASE IN SOYBEANSConstruction of Vectors for Transformation of Glycine max for Reduced Expression of Palmitoyl-ACP thioesterase in Developing Soybean Seeds
Plasmids containing the antisense G. max palmitoyl-ACP thioesterase cDNA sequence under control of the soybean beta-conglycinin promoter (Beachy et al., EMBO J. (1985) 4:3047-3053), were constructed. The construction of vectors expressing the soybean delta-12 desaturase antisense cDNA under the control of these promoters was facilitated by the use of plasmids pCW109 and pML18, both of which are described in [WO 9411516].
A unique Not I site was introduced into the cloning region between the beta-conglicinin promoter and the phaseolin 3' end in pCW109 by digestion with Nco I and Xba I followed by removal of the single stranded DNA ends with mung bean exonuclease. Not I linkers (New England Biochemical catalog number NEB 1125) were ligated into the linearized plasmid to produce plasmid pAW35. The single Not I site in pML18 was destroyed by digestion with Not I, filling in the single stranded ends with dNTP's and Klenow fragment followed by re-ligation of the linearized plasmid. The modified pML18 was then digested with Hind III and treated with calf intestinal phosphatase.
The beta-conglicinin:Not I:phaseolin expression cassette in pAW35 was removed by digestion with Hind III and the 1.79 kB fragment was isolated by agarose gel electrophoresis. The isolated fragment was ligated into the modified and linearized pML18 construction described above. A clone with the desired orientation was identified by digestion with Not I and Xba I to release a 1.08 kB fragment indicating that the orientation of the beta-conglycinin transcription unit was the same as the selectable marker transcription unit. The resulting plasmid was given the name pBS19.
PCR amplification primers SOYTE3 (5'-AAGGAAAAAAGCGGCCGCTGACACAATAGC CCTTCT-3') (SEQ ID NO:5) corresponding to bases 1 to 16 of SEQ ID NO:1 with additional bases to provide a Not I restriction site and sufficient additional bases to allow Not I digestion and SOYTE4 (5-AAGGAAAAAAGCGGCCGCGATTTACTGCTG CTTTTC-3') (SEQ ID NO:12) corresponding to the reverse complement of bases 1640 to 1657 of SEQ ID NO:1 with additional bases to provide a Not I restriction site and sufficient additional bases to allow Not I digestion were synthesiszed. Using these primers, pTE11 as template and standard PCR amplification proccedures (Perkin Elmer Cetus, GeneAmp PCR kit), a 1.6 kB fragment of p233b was amplified and isolated by agarose gel electrophoresis. The fragment was digested overnight at 37°C with Not I, extracted with phenol/chloroform followed by chloroform extraction and ethanol precipitation. Plasmid pBS19 was digested with Not I, treated with calf intestinal phosphatase and the linearized plasmid was purified by agarose gel electrophoresis. The Not I digested, PCR amplified fragment of pTE11 described above was ligated into the linearized pBS19 and the ligation mixture used to transform competent X1-1 cells. A clone in which the soybean palmitoyl-ACP cDNA was oriented in the antisense direction with respect to the beta-conglycinin promoter was identified by digestion with Hind III. The antisense orientation releases fragments of 1.6 and 1.9 kB while the sense orientation releases fragments of 1.15 and 2.3 kB. The antisense soybean palmitoyl-ACP thioesterase plasmid was designated pTC3 and the sense oriented plasmid was designated pTC4.
Transformation Of Somatic Soybean Embryo Cultures
Soybean embryogenic suspension cultures were maintained in 35 mL liquid media (SB55 or SBP6, MATERIALS AND METHODS) on a rotary shaker, 150 rpm, at 28°C with mixed fluorescent and incandescent lights on a 16:8 h day/night schedule. Cultures were subcultured every four weeks by inoculating approximately 35 mg of tissue into 35 mL of liquid medium.
Soybean embryogenic suspension cultures were transformed with pTC3 by the method of particle gun bombardment (see Kline et al. (1987) Nature (London) 327:70). A DuPont Biolistic PDS1000/HE instrument (helium retrofit) was used for these transformations.
To 50 mL of a 60 mg/mL 1 mm gold particle suspension was added (in order); 5 uL DNA(1 ug/uL), 20 uL spermidine (0.1 M), and 50 uL CaCl2 (2.5 M). The particle preparation was agitated for 3 min, spun in a microfuge for 10 sec and the supernatant removed. The DNA-coated particles were then washed once in 400 uL 70% ethanol and are suspended in 40 uL of anhydrous ethanol. The DNA/particle suspension was sonicated three times for 1 sec each. Five uL of the DNA-coated gold particles were then loaded on each macro carrier disk.
Approximately 300-400 mg of a four week old suspension culture was placed in an empty 60×15 mm petri dish and the residual liquid removed from the tissue with a pipette. For each transformation experiment, approximately 5-10 plates of tissue were normally bombarded. Membrane rupture pressure was set at 1000 psi and the chamber was evacuated to a vacuum of 28 inches of mercury. The tissue was placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue was placed back into liquid and cultured as described above.
Eleven days post bombardment, the liquid media was exchanged with fresh SB55 containing 50 mg/mL hygromycin. The selective media was refreshed weekly. Seven weeks post bombardment, green, transformed tissue was observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue was removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Thus each new line was treated as independent transformation event. These suspensions can then be maintained as suspensions of embryos clustered in an immature developmental stage through subculture or regenerated into whole plants by maturation and germination of individual somatic embryos.
Transformed embryogenic clusters were removed from liquid culture and placed on a solid agar media (SB103, MATERIALS AND METHODS) containing no hormones or antibiotics. Embryos were cultured for four weeks at 26°C with mixed fluorescent and incandescent lights on a 16:8 h day/night schedule before analysis.
Analysis Of Transgenic Glycine Max Embryos Containing An Antisense Palmitoyl-ACP Thioesterase Construct
The vector pTC3 containing the soybean palmitoyl-ACP thioesterase cDNA, in the antisense orientation, under the control of the soybean beta-conglycinin promoter as described above gave rise to seven mature embryo lines. A culture of the embryo line used for transformation was carried through culture to mature embryos without transformation or selection to serve as a fatty acid profile control line. Fatty acid analysis was performed by gas chromatography of the fatty acyl methyl esters essentially as described by Browse et al., (Anal. Biochem. (1986) 152:141-145) except that 25% H2 SO4 in methanol was used as the methylation reagent and samples were heated for 1.5 h at 80°C to effect the methanolysis of the embryo lipids using single, mature embryos as the tissue source. Nine to ten embryos from each transformed line and 5 embryos from the untransformed control were analyzed and the results are shown in Table 3.
| TABLE 3 |
| Fatty acids in control soybean embryos and in soybeans embryos |
| transformed with a vector expressing the soybean palmitoyl-ACP |
| thiosterase in the antisense orientation |
| FATTY ACID |
| AS % OF TOTAL FATTY ACIDS |
| EMBRYO LINE EMBRYO NO. 16:0 18:0 18:1 18:2 18:3 |
| 2872 control 1 12.7 4.6 20.8 53.1 7.9 |
| 2872 control 2 13.8 3.1 12.0 58.0 12.0 |
| 2872 control 3 15.9 3.9 11.2 53.9 13.9 |
| 2872 control 4 14.5 2.9 13.9 57.7 9.2 |
| 2872 control 5 15.8 4.4 13.4 51.8 12.4 |
| 353/3/1 1 6.4 2.1 11.3 63.1 17.0 |
| 353/3/1 2 13.3 3.0 14.5 53.9 14.3 |
| 353/3/1 3 6.9 2.0 11.2 62.9 16.9 |
| 353/3/1 4 12.1 2.8 9.6 55.8 19.5 |
| 353/3/1 5 5.8 1.9 12.3 64.1 15.4 |
| 353/3/1 6 10.1 2.3 11.8 57.3 17.7 |
| 353/3/1 7 3.9 2.0 17.9 64.1 12.1 |
| 353/3/1 8 8.2 2.4 11.0 61.1 16.4 |
| 353/3/1 9 8.0 2.4 10.5 59.9 18.3 |
| 353/3/1 10 5.1 1.9 13.2 66.8 12.5 |
| 353/3/2 1 6.3 2.0 12.0 62.2 17.4 |
| 353/3/2 2 9.1 2.5 11.1 60.5 16.5 |
| 353/3/2 3 8.3 2.1 11.0 61.3 16.4 |
| 353/3/2 4 15.1 2.9 10.1 51.8 19.4 |
| 353/3/2 5 6.4 2.1 15.5 60.3 15.5 |
| 353/3/2 6 16.1 2.9 11.1 53.5 15.9 |
| 353/3/2 7 7.6 2.0 10.3 64.5 15.0 |
| 353/3/2 8 5.5 2.1 12.1 64.6 15.7 |
| 353/3/2 9 15.9 3.0 9.5 51.8 19.1 |
| 353/3/2 10 5.8 2.0 12.8 63.7 14.9 |
| 353/3/3 1 7.6 2.5 10.9 61.2 15.9 |
| 353/3/3 2 5.4 4.1 20.4 40.2 7.9 |
| 353/3/3 3 5.2 1.9 12.6 67.2 12.4 |
| 353/3/3 4 4.5 2.0 25.8 54.7 9.1 |
| 353/3/3 5 6.7 1.8 11.7 62.1 16.1 |
| 353/3/3 6 6.0 1.5 10.3 63.2 17.3 |
| 353/3/3 7 6.6 2.5 9.4 65.4 15.0 |
| 353/3/3 8 13.2 2.9 21.6 49.9 11.6 |
| 353/3/3 9 13.4 3.2 16.4 52.5 12.7 |
| 357/1/1 1 8.3 2.1 12.3 63.7 12.8 |
| 357/1/1 2 11.1 2.8 11.1 59.3 14.2 |
| 357/1/1 3 7.5 2.1 14.1 63.1 12.2 |
| 357/1/1 4 7.7 2.4 13.8 62.7 12.4 |
| 357/1/1 5 14.2 3.0 10.5 58.2 12.7 |
| 357/1/1 6 11.8 2.5 11.3 61.7 12.7 |
| 357/1/1 7 13.8 3.2 10.1 56.1 14.8 |
| 357/1/1 8 6.3 1.6 12.8 65.8 12.4 |
| 357/1/1 9 10.5 2.8 11.2 57.5 16.7 |
| 357/1/1 10 7.2 1.9 13.8 62.1 14.1 |
| 357/1/2 1 3.4 1.6 18.6 64.6 11.8 |
| 357/1/2 2 3.7 1.5 19.0 65.1 11.6 |
| 357/1/2 3 5.2 1.4 21.6 56.4 15.5 |
| 357/1/2 4 3.9 1.5 12.7 69.5 12.4 |
| 357/1/2 5 4.9 1.6 12.2 68.3 12.9 |
| 357/1/2 6 4.3 2.0 14.3 66.2 13.0 |
| 357/1/2 7 10.5 2.5 12.9 57.7 16.2 |
| 357/1/2 8 6.4 1.8 24.7 53.4 11.7 |
| 357/1/2 9 11.8 2.3 9.0 57.1 19.4 |
| 357/1/2 10 3.1 1.4 14.8 62.3 12.1 |
| 357/1/3 1 11.5 2.3 9.7 61.5 14.8 |
| 357/1/3 2 9.9 2.3 9.5 64.2 14.0 |
| 357/1/3 3 12.7 2.9 13.5 57.3 11.5 |
| 357/1/3 4 13.9 3.0 14.3 51.1 16.7 |
| 357/1/3 5 14.7 3.0 13.0 53.0 16.3 |
| 357/1/3 6 11.8 2.4 9.9 58.3 17.7 |
| 357/1/3 7 11.3 2.3 10.1 60.6 15.1 |
| 357/1/3 8 11.7 2.4 9.9 61.3 14.2 |
| 357/1/3 9 14.4 2.5 5.5 63.3 14.3 |
| 357/1/3 10 9.6 2.2 18.7 57.0 12.4 |
| 357/5/1 1 4.0 1.3 17.7 63.1 13.3 |
| 357/5/1 2 3.8 1.3 16.9 65.0 12.4 |
| 357/5/1 3 2.9 1.8 17.6 65.4 11.6 |
| 357/5/1 4 4.1 1.4 13.6 66.0 14.0 |
| 357/5/1 5 2.8 1.5 17.0 67.3 10.9 |
| 357/5/1 6 6.3 1.9 14.3 61.2 15.5 |
| 357/5/1 7 3.4 1.0 14.9 68.9 11.1 |
| 357/5/1 8 4.5 1.5 17.0 62.4 14.0 |
| 357/5/1 9 2.9 0.9 14.5 70.5 18.6 |
| 357/5/1 10 3.1 1.1 14.9 69.1 11.0 |
The average palmitate content of six of the seven transformed lines is significantly less than that of the control embryo line. In each of these six lines, the average stearate content is also less than the control average. This result is expected if the palmitoyl-ACP thioesterase is responsible for the release of all or part of the palmitate that is incorporated into triacylglyceride and if the antisense construction has reduced the amount of palmitoyl-ACP thioesterase produced. Since the stearate content of the lines is decreased rather than increased in correspondence with the decreased palmitate, the following may be inferred: The capacity to elongate palmitoyl-ACP to stearoyl-ACP must be sufficient to convert the increased flux to stearate, and the capacity to desaturate stearoyl-ACP to oleoly-ACP must also be sufficient to convert the increased flux to oleate. These two events lead to a significant decrease in the total saturated fatty acids produced in the transformed embryos. It may also be inferred that the oleate desaturating capacity is present in excess of the substrate supplied to it since most of the carbon which was not removed from the ACP synthetic track is found in the linoleate fraction.
This is seen most clearly in a comparison of lines 357/1/3 and 357/5/1. Line 357/1/3 was transformed but shows little or no alteration in fatty acid phenotype while line 357/5/1 is quite uniform among all tested embryos in producing an altered fatty acid phenotype. The average palmitic acid content of the lipid in line 357/5/1 is 3.2 fold less than that of line 357/1/3 and the average stearic acid content of 357/1/3 is 1.8 fold less than that of line 357/5/1. The combined saturated fatty acid decrease is 12.2% of the total fatty acid, and of that 12.2%, nearly all (11.7%) can be accounted for as increased oleate and linoleate.
Thus, the combined effect is a soybean embryo line with 65% less saturated fatty acid and with increased monounsaturated and polyunsaturated fatty acid.
From this data we conclude that reduction of the amount of palmitoyl-ACP thioesterase expressed in developing soybean seeds will lead to the production of soybean oil with reduced saturated fatty acid content. The variation in the amount of antisense effect observed between embryos but within a transformed line seen in Table 3 is a characteristic of this transformation system which is explained more fully below. The relation between data taken from the immature embryos and seeds from the zygotic embryos produced on plants regenerated from these somatic embryos is dicussed below.
The Fatty Acid Phenotype Resulting From Antisense Or Co-Suppression Inhibition Of Gene Expression In Soybean Somatic Embryos Is Predictive Of The Fatty Acid Phenotype Of Seeds Of Plants Regenerated From Those Embryos
Mature somatic soybean embryos are a good model for zygotic embryos. While in the globular embryo state in liquid culture, somatic soybean embryos contain very low amounts of triacylglycerol or storage proteins, typical of maturing, zygotic soybean embryos. At this developmental stage, the ratio of total triacylglyceride to total polar lipid (phospholipids and glycolipid) is about 1:4, as is typical of zygotic soybean embryos at the developmental stage from which the somatic embryo culture was initiated. At the globular stage as well, the mRNAs for the prominent seed proteins, alpha' subunit of beta-conglycinin, kunitz trypsin inhibitor 3, and seed lectin are essentially absent. Upon transfer to hormone-free media to allow differentiation to the maturing somatic embryo state, triacylglycerol becomes the most abundant lipid class. As well, mRNAs for alpha'-subunit of beta-conglycinin, kunitz trypsin inhibitor 3 and seed lectin become very abundant messages in the total mRNA population. On this basis the somatic soybean embryo system behaves very similarly to maturing zygotic soybean embryos in vivo, and is therefore a good and rapid model system for analyzing the phenotypic effects of modifying the expression of genes in the fatty acid biosynthesis pathway.
Most importantly, the model system is also predictive of the fatty acid composition of seeds from plants derived from transgenic embryos. This is illustrated with two different antisense constructs in two different types of experiment and in a similar co-suppression experiment:
Liquid culture globular embryos transformed with a chimeric gene consisting of soybean microsomal delta-15 desaturase (experiment 1, WO 9311245) or soybean microsomal delta-12 desaturase (experiment 2) in antisense orientation under the control of a seed-specific promoter (beta-conglycinin promoter) gave rise to mature embryos. The fatty acid content of mature somatic embryos from lines transformed with vector only (control) and the vector containing the antisense chimeric genes as well as of seeds of plants regenerated from them was determined. In experiment 1, one set of embryos from each line was analyzed for fatty acid content and another set of embryos from that same line was regenerated into plants. In experiment 2, different lines, containing the same antisense construct, were used for fatty acid analysis in somatic embryos and for regeneration into plants. In experiment 1, in all cases where a reduced 18:3 content was seen in a transgenic embryo line, compared with the control, a reduced 18:3 content was also observed in segregating seeds of plants derived from that line, when compared with the control seed (Table 4).
In experiment 2, about 55% of the transformed embryo lines showed an increased 18:1 content when compared with control lines (Table 5). Soybean seeds, of plants regenerated from different somatic embryo lines containing the same antisense construct, had a similar frequency (53%) of high oleate transformants as the somatic embryos (Table 5). On occasion, an embryo line may be chimeric. That is, 10-70% of the embryo in a line may not contain the transgene. The remaining embryos which do contain the transgene, have been found in all cases to be clonal. In such a case, plants with both wild type and transgenic phenotypes may be regenerated from a single, transgenic line, even if most of the embryos analyzed from that line had a transgenic phenotype. An example of this is shown in Table 6 in which of 5 plants regenerated from a single embryo line, 3 have a high oleic phenotype and two were wild type. In most cases, all the plants regenerated from a single transgenic line will have seeds containing the transgene.
| TABLE 4 |
| Percent 18:3 Content of Embryos And Seeds Of Control and Delta-15 |
| Antisense Construct Transgenic Soybean Lines |
| Embryo average Seed average* |
| Transformant Line (SD n = 10) (SD, n = 10) |
| Control 12.1 (2.6) 8.9 (0.8) |
| Δ15 antisense, line 1 5.6 (1.2) 4.3 (1.6) |
| Δ15 antisense, line 2 8.9 (2.2) 2.5 (1.8) |
| Δ15 antisense, line 3 7.3 (1.1) 4.9 (1.9) |
| Δ15 antisense, line 4 7.0 (1.9) 2.4 (1.7) |
| Δ15 antisense, line 5 8.5 (1.9) 4.5 (2.2) |
| Δ15 antisense, line 6 7.6 (1.6) 4.6 (1.6) |
| *[Seeds which were segregating with wild-type phenotype and without a copy |
| of the transgene are not included in these averages] |
| TABLE 4 |
| Percent 18:3 Content of Embryos And Seeds Of Control and Delta-15 |
| Antisense Construct Transgenic Soybean Lines |
| Embryo average Seed average* |
| Transformant Line (SD n = 10) (SD, n = 10) |
| Control 12.1 (2.6) 8.9 (0.8) |
| Δ15 antisense, line 1 5.6 (1.2) 4.3 (1.6) |
| Δ15 antisense, line 2 8.9 (2.2) 2.5 (1.8) |
| Δ15 antisense, line 3 7.3 (1.1) 4.9 (1.9) |
| Δ15 antisense, line 4 7.0 (1.9) 2.4 (1.7) |
| Δ15 antisense, line 5 8.5 (1.9) 4.5 (2.2) |
| Δ15 antisense, line 6 7.6 (1.6) 4.6 (1.6) |
| *[Seeds which were segregating with wild-type phenotype and without a copy |
| of the transgene are not included in these averages] |
| TABLE 4 |
| Percent 18:3 Content of Embryos And Seeds Of Control and Delta-15 |
| Antisense Construct Transgenic Soybean Lines |
| Embryo average Seed average* |
| Transformant Line (SD n = 10) (SD, n = 10) |
| Control 12.1 (2.6) 8.9 (0.8) |
| Δ15 antisense, line 1 5.6 (1.2) 4.3 (1.6) |
| Δ15 antisense, line 2 8.9 (2.2) 2.5 (1.8) |
| Δ15 antisense, line 3 7.3 (1.1) 4.9 (1.9) |
| Δ15 antisense, line 4 7.0 (1.9) 2.4 (1.7) |
| Δ15 antisense, line 5 8.5 (1.9) 4.5 (2.2) |
| Δ15 antisense, line 6 7.6 (1.6) 4.6 (1.6) |
| *[Seeds which were segregating with wild-type phenotype and without a copy |
| of the transgene are not included in these averages] |
In a similar experiment, 75% of the coding region (begininng at the 5' end) of the delta-12 desaturase sequence and of the delta-15 desaturase sequence were each placed behind the b-conglycinin promoter in a single construction for soybean transformation as described above. As in experiment 2 above, seperate embryo sets were used for analysis at the embryo stage and regeneration into fertile plants. The average 18:1 and 18:3 content in five embryos from each of 7 transformed lines is given in Table 7. Of the 7 lines two clearly have elevated levels of 18:1 as would be expected of embryos in which the conversion of 18:1 to 18:2 by delta-12 desaturase is limited due to decreased expression of the enzyme. In these same lines there is a slight decrease in the 18:3 content, indicative of a decreased delta-15 desaturase activity.
| TABLE 7 |
| The 18:1 and 18:3 content in somatic embryos from seven lines |
| transformed with a combined Delta-12 and Delta-15 co-suppression |
| construct. Values are the mean of five individual embryos |
| Line % 18:1 % 18:3 |
| 561/1/3 45.1 10.1 |
| 561/1/2 18.4 13.8 |
| 561/1/3 10.7 15.2 |
| 561/4/1 39.3 13.4 |
| 561/4/2 38.7 13.2 |
| 561/4/4 19.7 14.1 |
| 561/4/5 14.6 16.1 |
| 561/4/6 43.9 12.9 |
Twenty, fertile soybean plants were regenerated from somatic embryos transformed with the combined D12/D15 desaturase co-suppression construction described above. Five single seeds from each plant were analyzed and of the twenty lines, two showed bulk fatty acid profiles which suggested that both the D 12 and D 15 desaturase activities were decreased. The first seeds from transformed plants should be genetically segregating for the transgene so single seeds from these two lines were analyzed to derive an estimate of the number of transgene loci contributing to the fatty acid phenotype. Ninty nine seeds of line 557-2-8-1 were analyzed and 137 seeds of line 557-2-8-2 were analyzed. The fatty acid profile classes from both lines were consistent with two transgenic loci contributing to the phenotype. The average fatty acid profile of the seeds which were judged to be in the high segregant class are given in Table 8 for both of these lines.
| TABLE 8 |
| The average fatty acid profiles (as % of total fatty acids) for the |
| probable |
| double homozygous seeds from two lines segreating for co-suppression |
| transgenes for the Δ12 and Δ15 desaturases. The data are the |
| mean of 10 |
| single seed profies for line 557-2-8-1 and 13 single seed profiles for line |
| 557-2-8-2. The profile from a non-transformed line grown along with the |
| transformed lines in shown for comparison. |
| Line 16:0 18:0 18:1 18:2 18:3 |
| 557-2-8-1 8.6 2.1 82.5 2.5 4.2 |
| 557-2-8-2 8.3 2.1 82.0 2.2 5.0 |
| non-transformed 13.3 2.4 17.4 52.3 19.2 |
As with the antisense constructions, the fatty acid profiles observed in the somatic embryos is predictive of the type and magnitude of alteration in fatty acid profile which will be obtained from the seeds of fertile plants transformed with the same construction as the somatic embryos. Thus, we conclude that an altered fatty acid phenotype observed in a transgenic, mature somatic embryo line is predictive of an altered fatty acid composition of seeds of plants derived from that line.
Analysis Of Transgenic Glycine Max Embryos Containing A Palmitoyl-ACP Thioesterase Construct In The Sense Orientation
The vector pTC4 containg the soybean palmitoyl-ACP thioesterase cDNA, in the sense orientation, under the control of the soybean beta-conglycinin promoter as described above gave rise to six mature embryo lines in the soybean somatic embryo system. From 6 to 10 embryos from each of these lines were analyzed for relative content of each fatty acid as described above. The results are shown in Table 9.
| TABLE 9 |
| FATTY ACID |
| AS % OF TOTAL FATTY ACIDS |
| EMBRYO LINE EMBRYO NO. 16:0 18:0 18:1 18:2 18:3 |
| 361/1/1 1 14.8 3.3 10.9 54.9 14.5 |
| 361/1/1 2 13.1 2.7 10.2 56.9 16.3 |
| 361/1/1 3 11.7 3.0 14.5 57.4 12.4 |
| 361/1/1 4 10.0 3.1 24.1 50.4 11.6 |
| 361/1/1 5 10.9 2.6 17.9 54.6 12.9 |
| 361/1/1 6 10.5 3.1 27.5 47.3 10.6 |
| 361/1/1 7 9.8 3.4 31.5 43.9 10.5 |
| 361/1/1 8 10.5 3.4 23.7 50.0 11.1 |
| 361/1/1 9 15.0 3.5 9.6 57.5 13.4 |
| 361/1/1 10 12.8 3.1 15.7 52.6 12.0 |
| 361/1/2 1 3.9 2.3 16.1 66.7 10.1 |
| 361/1/2 2 10.2 3.3 26.4 47.5 11.7 |
| 361/1/2 3 4.7 2.3 20.8 60.0 11.4 |
| 361/1/2 4 3.7 2.5 27.0 56.9 8.8 |
| 361/1/2 5 3.9 3.1 37.7 45.5 6.4 |
| 361/1/2 6 3.5 2.0 16.6 67.2 9.4 |
| 361/2/1 1 13.1 2.9 10.8 55.8 16.7 |
| 361/2/1 2 12.0 2.5 11.2 57.3 16.2 |
| 361/2/1 3 13.5 3.0 13.2 55.2 3.6 |
| 361/2/1 4 13.5 2.8 11.6 56.4 14.9 |
| 361/2/1 5 15.3 3.0 7.0 56.9 17.0 |
| 361/2/1 6 13.1 2.2 10.1 59.0 14.1 |
| 361/2/1 7 13.4 2.9 12.5 56.9 13.6 |
| 361/2/1 8 15.1 4.0 13.9 49.4 16.5 |
| 361/2/1 9 15.7 3.3 11.2 54.6 13.8 |
| 361/2/1 10 13.1 2.7 11.5 58.0 13.8 |
| 361/2/2 1 4.4 1.5 40.3 40.9 12.9 |
| 361/2/2 2 29.2 3.6 12.8 42.2 11.2 |
| 361/2/2 3 2.4 1.0 37.1 45.0 14.4 |
| 361/2/2 4 1.7 0.7 46.6 37.3 14.4 |
| 361/2/2 5 3.4 1.5 31.2 51.6 12.4 |
| 361/2/2 6 4.1 1.4 29.6 46.2 20.1 |
| 361/2/2 7 3.7 1.2 37.8 40.1 16.4 |
| 361/2/2 8 3.6 1.5 35.4 46.2 13.3 |
| 361/2/2 9 5.6 2.4 41.1 31.7 17.6 |
| 361/5/1 1 13.7 2.5 11.8 57.8 13.4 |
| 361/5/1 2 27.2 3.6 9.8 46.3 11.8 |
| 361/5/1 3 16.8 2.8 12.8 53.4 13.4 |
| 361/5/1 4 14.6 2.5 11.4 56.6 14.2 |
| 361/5/1 5 25.9 4.0 13.8 42.9 12.5 |
| 361/5/1 6 25.1 3.3 10.3 49.3 11.0 |
| 361/5/1 7 27.2 3.0 4.9 46.6 15.6 |
| 361/5/1 8 27.0 3.8 9.8 44.9 13.1 |
| 361/5/1 9 25.5 3.5 10.1 45.5 11.2 |
| 361/5/1 10 22.8 4.1 14.0 46.1 11.9 |
| 361/5/2 1 28.7 3.5 9.8 44.3 12.7 |
| 361/5/2 2 31.0 3.5 8.7 43.5 12.4 |
| 361/5/2 3 20.2 3.7 9.8 51.0 14.2 |
| 361/5/2 4 26.6 3.4 12.9 44.2 11.8 |
| 361/5/2 5 27.3 3.5 9.3 44.4 12.4 |
| 361/5/2 6 25.9 3.5 11.6 45.2 12.7 |
| 361/5/2 7 25.6 3.7 9.2 46.5 13.4 |
| 361/5/2 8 25.3 3.7 11.2 46.5 12.3 |
| 363/5/2 9 24.5 3.5 9.6 46.4 14.5 |
| 361/5/2 10 26.6 3.7 9.8 44.9 14.0 |
As is often the case when increasing the expression of an mRNA which is endogenous to the targeted tissue, the effects of both over-expression of the resulting enzyme and under expresssion of the enzyme due to co-supression are seen in this experiment. While lines 361/1/1 and 361/2/1 have fatty acid profiles very similar to control lines (shown in Table 9), most of the embryos in line 361/1/2 have levels of palmitic acid which are about 3 fold lower than controls or transformed lines which do not show altered fatty acid phenotype. In contrast, the palmitic acid content of all of the embryos in line 361/5/2 is increased and the average palmitic acid content is 26.2% or 1.8 times the average control embryo. Line 361/2/2 contains 8 embryos which show the co-supression phenotype (low palmitic acid) and one embryo which shows the over expression phenotype (high palmitic acid content).
In this experiment the effects of altered expression of the soybean palmitoyl-ACP thioesterase are seen in both directions, and the resulting phenotypes are as expected from the substrate specificity of the enzyme. Modulation of expression upward increases the relative palmitic acid content and downward decreases the relative palmitic acid content.
PAC REGULATION OF EXPRESSION OF PALMITOYL-ACP THIOESTERASE IN CANOLAConstruction Of Vectors For Transformation Of Brassica Napus For Reduced Expression Of Palmitoyl-ACP thioesterase In Developing Canola Seeds
An extended poly A tail was removed from the canola palmitoyl-ACP thioesterase sequence contained in plasmid p5b as follows. Plasmid p5b was digested with Eco RI and Ssp I and the 1.5 kB fragment released from the pBluescript vector was isolated by agarose gel electrophoresis. The single stranded ends were filled in with Klenow fragment and dNTP's.
Canola napin promoter expression cassettes were constructed as follows: Eight oligonucleotide primers were synthesized based upon the nucleotide sequence of napin lambda clone CGN1-2 published in European Patent 255 378. The oligonucleotide sequences were:
BR42: 5'-AACATCAATGGCAGCAACTGCGGA-3' SEQ ID NO:13
BR43: 5'-GCCGGCTGGATTGTGGCATCAT-3' SEQ ID NO:14
BR45: 5'-CTAGATCTCCATGGGTGTATGTTCTGTAG TGATG-3' SEQ ID NO:15
BR46: 5'-TCAGGCCTGTCGACCTGCGGATCA AGCAGCTTTCA-3' SEQ ID NO:16
BR47: 5'-CTAGATCTGGTACCTAGATTCCAAACGAAI ATCCT-3' SEQ ID NO:17
BR48: 5'-AACATCAGGCAAGTTAGCATTTGC-3' SEQ ID NO:18
BR49: 5'-TCAGGCCTGTCGACGAGGTCCTTCGTCAGC ATAT-3' SEQ ID NO:19
BR50: 5'-AACGAACCAATGACTTCACTGGGA-3' SEQ ID NO:20
Genomic DNA from the canola variety `Hyola401` (Zeneca Seeds) was used as a template for PCR amplification of the napin promoter and napin terminator regions. The promoter was first amplified using primers BR42 and BR43, and reamplified using primers BR45 and BR46. Plasmid plMC01 was derived by digestion of the 1.0 kb promoter PCR product with SalI/BglII and ligation into SalI/BamHI digested pBluescript SK+(Stratagene). The napin terminator region was amplified using primers BR48 and BR50, and reamplified using primers BR47 and BR49. Plasmid plMC06 was derived by digestion of the 1.2 kb terminator PCR product with SalI/BglII and ligation into SalI/BglII digested pSP72 (Promega). Using plMC06 as a template, the terminator region was reamplified by PCR using primer
BR57 5'-CCATGGGAGCTCGTCGACGAGGTCCTT CGTCACGAT-3' SEQ ID NO:21 and primer
BR58 5'-GAGCTCCCATGGAGATCTGGTACCTAG ATTCCAAAC-3' SEQ ID NO:22
Plasmid plMC101 containing both the napin promoter and terminator was generated by digestion of the PCR product with Sacl/Ncol and ligation into Sacl/Ncol digested pIMC01. Plasmid plMC101 contains a 22 kb napin expression cassette including complete napin 5' and 3' non-translated sequences and an introduced Ncol site at the translation start ATG. Primer
BR61 5'-GACTATGTTCTGAATTCTCA-3' SEQ ID NO:23 and primer
BR62 5'-GACAAGATCTGCGGCCGCTAAAGAGTG AAGCCGAGGCTC-3' SEQ ID NO:24
were used to PCR amplify an 770 bp fragment from the 3' end of the napin promoter. Plasmid plMC401 was obtained by digestion of the resultant PCR product with EcoRI/BglII and ligation into EcoRI/BglII digested plMC 101. Plasmid plMC40 1 contains a 2.2 kb napin expression cassette lacking the napin 5' non-translated sequence and includes a Notl site at the transcription start.
The oligonucleotide sequences were:
BR42 and BR43 corresponding to bases 29 to 52 (BR42) and the complement of bases 1146 to 1169 (BR43) of SEQ ID NO:8.
BR45 and BR46 corresponding to bases 46 to 66 (BR46) and the complement of bases 1028 to 1047 (BR45) of SEQ ID NO:8. In addition BR46 had bases corresponding to a Sal I site (5'-GTCGAC-3') and a few additional bases (5'-TCAGGCCT-3') at its 5' end and BR45 had bases corresponding to a Bgl II site (5'-AGATCT-3') and two (5'-CT-3') additional bases at the 5' end of the primer.
BR47 and BR48 corresponding to bases 81 to 102 (BR47) and bases 22 to 45 (BR48) of SEQ ID NO:10. In addition, BR47 had two (5'-CT-3') additional bases at the 5' end of the primer followed by bases corresponding to a Bgl II site (5'-AGATCT-3') followed by a few additional bases (5'-TCAGGCCT-3'),
BR49 and BR50 corresponding to the complement of bases 1256 to 1275 (BR49) and the complement of bases 1274 to 1297 (BR50) of SEQ ID NO:10. In addition BR49 had bases corresponding to a Sal I site (5'-GTCGAC-3') and a few additional bases (5'-TCAGGCCT-3) at its 5' end.
BR57 and BR58 corresponding to the complement of bases 1258 to 1275 (BR57) and bases 81 to 93 (BR58) of SEQ ID NO: 10. In addition the 5' end of BR57 had some extra bases (5'-CCATGG-3') followed by bases corresponding to a Sac I site (5'-GAGCTC-3') followed by more additional bases (5'-GTCGACGAGG-3') (SEQ ID NO:25). The 5' end of BR58 had additional bases (5'-GAGCTC-3') followed by bases corresponding to a Nco I site (5'-CCATGG-3') followed by additional bases (5' AGATCTGGTACC-3') (SEQ ID NO:26).
BR61 and BR62 corresponding to bases 745 to 764 (BR61) and bases 993 to 1013 (BR62) of SEQ ID NO:8. In addition the 5' end of BR 62 had additional bases (5'-GACA-3') followed by bases corresponding to a Bgl II site (5'-AGATCT-3') followed by a few additional bases (5'-GCGGCCGC-3').
Genomic DNA from the canola variety `Hyola401` (Zeneca Seeds) was used as a template for PCR amplification of the napin promoter and napin terminator regions. The promoter was first amplified using primers BR42 and BR43, and reamplified using primers BR45 and BR46. Plasmid pIMC01 was derived by digestion of the 1.0 kb promoter PCR product with SalI/BglII and ligation into SalI/BamHI digested pBluescript SK+(Stratagene). The napin terminator region was amplified using primers BR48 and BR50, and reamplified using primers BR47 and BR49. Plasmid pIMC06 was derived by digestion of the 1.2 kb terminator PCR product with SalI/BglII and ligation into SalI/BglII digested pSP72 (Promega). Using pIMC06 as a template, the terminator region was reamplified by PCR using primer BR57 and primer BR58. Plasmid pIMC101 containing both the napin promoter and terminator was generated by digestion of the PCR product with SacI/NcoI and ligation into SacI/NcoI digested pIMC01. Plasmid pIMC101 contains a 2.2 kb napin expression cassette including complete napin 5' and 3' non-translated sequences and an introduced NcoI site at the translation start ATG. Primer BR61 and primer BR62 were used to PCR amplify an ∼270 bp fragment from the 3' end of the napin promoter. Plasmid pIMC401 was obtained by digestion of the resultant PCR product with EcoRI/BglII and ligation into EcoRI/BglII digested pIMC101. Plasmid pIMC401 contains a 2.2 kb napin expression cassette lacking the napin 5' non-translated sequence and includes a NotI site at the transcription start.
Plasmid pIMC401 was digested with Not I and the single stranded ends filled with dNTP's and Klenow fragment. The linearized plasmid was treated with calf intestinal phosphatase. The phospatase treated and linearized plasmid was ligated to the blunted, 15 kB fragment of canola palmitoyl-ACP thioesterase described above. Transformation of competent E. coli cells with the ligation mixture resulted in the isolation of clones in which the plant cDNA sequence was in the sense orientation with respect to the napin promoter plMC29) and in the antisense orientation (pIMC30).
The vector for transformation of the antisense palmitoyl-ACP thioesterase construction under control of the napin promoter into plants using Agrobacterium tumefaciens was produced by constructing a binary Ti plasmid vector system (Bevan, (1984) Nucl. Acids Res. 12:8711-8720). One starting vector for the system, (pZS199) is based on a vector which contains: (1) the chimeric gene nopaline synthase/neomycin phosphotransferase as a selectable marker for transformed plant cells (Brevan et al. (1984) Nature 304:184-186), (2) the left and right borders of the T-DNA of the Ti plasmid (Brevan et al. (1984) Nucl. Acids Res. 12:8711-8720), (3) the E. coli lacZ α-complementing segment (Vieria and Messing (1982) Gene 19:259-267) with unique restriction endonuclease sites for Eco RI, Kpn I, Bam HI, and Sal I, (4) the bacterial replication origin from the Pseudomonas plasmid pVS1 (Itoh et al. (1984) Plasmid 11:206-220), and (5) the bacterial neomycin phosphotransferase gene from Tn5 (Berg et al. (1975) Proc. Natnl. Acad. Sci. U.S.A. 72:3628-3632) as a selectable marker for transformed A. tumefaciens. The nopaline synthase promoter in the plant selectable marker was replaced by the 35S promoter (Odell et al. (1985) Nature, 313:810-813) by a standard restriction endonuclease digestion and ligation strategy. The 35S promoter is required for efficient Brassica napus transformation as described below.
The binary vectors containing the sense and antisense palmitoyl-ACP thioesterase expression cassettes were constructed by digesting pIMC29 and pIMC30 with Sal I to release the napin:palmitoyl-ACP thioesterase cDNA:napin 3' sequence and agarose gel purification of the 3.8 kB fragments. Plasmid pZS199 was also digested with Sal I and the 3.8 kB fragments isolated from pIMC29 and pIMC30 were ligated into the linearized vector. Transformation and isolation of clones resulted in the binary vector containing the sense construct (pIMC129) and the antisense construct (pIMC130).
Agrobacterium-Mediated Transformation Of Brassica Napus
The binary vectors pIMC129 and pIMC130 were transferred by a freeze/thaw method (Holsters et al. (1978) Mol. Gen. Genet. 163:181-187) to the Agrobacterium strain LBA4404/pAL4404 (Hockema et al. (1983), Nature 303:179-180).
Brassica napus cultivar "Westar" was transformed by co-cultivation of seedling pieces with disarmed Agrobacterium tumefaciens strain LBA4404 carrying the the appropriate binary vector.
B. napus seeds were sterilized by stirring in 10% Chlorox, 0.1% SDS for thirty min, and then rinsed thoroughly with sterile distilled water. The seeds were germinated on sterile medium containing 30 mM CaCl2 and 1.5% agar, and grown for six days in the dark at 24°C
Liquid cultures of Agrobacterium for plant transformation were grown overnight at 28°C in Minimal A medium containing 100 mg/L kanamycin. The bacterial cells were pelleted by centrifugation and resuspended at a concentration of 108 cells/mL in liquid Murashige and Skoog Minimal Organic medium containing 100 μM acetosyringone.
B. napus seedling hypocotyls were cut into 5 mm segments which were immediately placed into the bacterial suspension. After 30 min, the hypocotyl pieces were removed from the bacterial suspension and placed onto BC-28 callus medium containing 100 μM acetosyringone. The plant tissue and Agrobacteria were co-cultivated for three days at 24°C in dim light.
The co-cultivation was terminated by transferring the hypocotyl pieces to BC-28 callus medium containing 200 mg/L carbenicillin to kill the Agrobacteria, and 25 mg/L kanamycin to select for transformed plant cell growth. The seedling pieces were incubated on this medium for three weeks at 24°C under continuous light.
After three weeks, the segments were transferred to BS-48 regeneration medium containing 200 mg/L carbenicillin and 25 mg/L kanamycin. Plant tissue were subcultured every two weeks onto fresh selective regeneration medium, under the same culture conditions described for the callus medium. Putatively transformed calli grow rapidly on regeneration medium; as calli reach a diameter of about 2 mm, they are removed from the hypocotyl pieces and placed on the same medium lacking kanamycin.
Shoots begin to appear within several weeks after transfer to BS-48 regeneration medium. As soon as the shoots form discernable stems, they are excised from the calli, transferred to MSV-1A elongation medium, and moved to a 16:8-h photoperiod at 24°C
Once shoots have elongated several internodes, they are cut above the agar surface and the cut ends are dipped in Rootone. Treated shoots are planted directly into wet MetroMix 350 soiless potting medium. The pots are covered with plastic bags which are removed when the plants are clearly growing--after about ten days.
Plants are grown under a 16:8-h photoperiod, with a daytime temperature of 23°C and a nightime temperature of 17°C When the primary flowering stem begins to elongate, it is covered with a mesh pollen-containment bag to prevent outcrossing. Self-pollination is facilitated by shaking the plants several times each day, and seeds mature by about 90 days following transfer to pots.
The relative content of each of the 7 main fatty acids in the seed lipid was analyzed as follows: Twenty seeds taken at random from a sample of 25 pods from each plant were ground in 0.5 mL of 2-propanol. Twenty five μL of the resulting extract was transferred to a glass tube and the solvent evaporated under a nitrogen stream. The dry residue was subjected to methanolysis in 0.5 mL of 1% sodium methoxide in methanol at 60° C. for 1 hour. The fatty acid methyl esters produced were extracted into 1 mL of hexane and 0.5 mL of water was added to the solvent mixture to wash methanol from the hexane layer. A portion of the hexane layer was transferred to a sample vial for analysis by gas-liquid chromatography as described in Example 3 above. While seven fatty acids were analyzed, only the relative contribution of the 5 main fatty acids to the total are shown in Tables 10, 11 and 12 below.
| TABLE 10 |
| The relative contribution of 5 fatty acids to the bulk seed fatty acid |
| content in segregating canola plants transformed with pIMC129 containing |
| the canola palmitoyl-ACP thioesterase in the sense orientation to the |
| Napin promotor |
| FATTY ACID |
| AS % OF TOTAL FATTY ACIDS |
| TRANSFORMANT NO. 16:0 18:0 18:1 18:2 18:3 |
| 129-511 4.1 1.4 67.9 19.0 5.9 |
| 129-186 4.2 1.4 66.5 20.0 5.9 |
| 129-230 4.2 1.2 63.9 21.0 7.9 |
| 129-258 4.0 1.4 57.2 25.5 30.0 |
| 129-107 4.7 1.7 59.0 24.1 8.4 |
| 129-457 4.3 1.3 62.0 22.8 7.7 |
| 129-381 4.2 1.1 58.0 24.8 10.0 |
| 129-515 4.4 1.3 63.4 21.8 7.5 |
| 129-122 4.0 1.4 63.0 21.4 8.4 |
| 129-176 4.1 1.4 65.7 19.6 7.5 |
| 129-939 4.4 1.7 64.8 19.2 8.2 |
| 129-303 4.2 1.5 62.3 21.4 9.4 |
| 129-208 3.8 1.4 66.9 18.0 8.2 |
| 129-835 4.3 1.6 58.0 24.5 9.7 |
| 129-659 4.0 1.6 60.8 22.2 10.0 |
| 129-44 4.2 1.8 66.0 18.4 7.7 |
| 129-756 3.9 1.6 60.0 22.4 10.0 |
| 129-30 4.0 1.7 64.8 18.7 9.6 |
| 129-340 3.8 1.7 67.1 17.4 7.9 |
| 129-272 3.9 1.8 59.4 21.3 12.0 |
| 129-358 4.2 1.5 60.7 20.8 11.0 |
| 129-223 4.3 1.6 63.4 20.6 8.1 |
| 129-314 4.1 2.1 61.8 21.4 9.4 |
| 129-657 4.2 1.8 64.8 18.3 9.3 |
| 129-151 4.2 1.4 82.5 20.8 9.2 |
| 129-40 4.3 1.6 63.8 20.5 7.8 |
| 129-805 4.4 2.2 61.6 19.4 10.0 |
| 129-44 4.1 1.6 64.2 19.1 8.7 |
| 129-288 3.5 1.5 65.1 15.9 8.9 |
| 129-833 4.2 1.7 58.8 23.6 9.4 |
| 129-889 4.6 2.8 57.6 26.4 9.1 |
| 129-247 5.7 1.5 52.8 27.2 13.0 |
| 129-355 4.3 2.3 66.0 19.1 6.4 |
| 129-631 4.5 2.3 66.7 19.4 5.6 |
| 129-73 5.0 2.5 65.4 20.8 6.4 |
| 129-407 3.9 1.5 65.4 22.2 6.1 |
| westar 4.0 1.7 64.0 19.7 8.5 |
None of the transformed plants analyzed have fatty acid profiles which are markedly different from that expected in canola seeds. Plants number 129-805, 129-889, and 129-73 are slightly elevated in their saturated fatty acid content and may represent lines with a low amount of over expression. Since the transformation event gives rise to a plant which is heterozygous for the introduced transgene, the seed from these plants is segregating with respect to the transgene copy number. If, as expected, the fatty acid phenotype is additive with respect to the transgene copy number, the full effect cannot be seen in bulk seed population until the second generation past transformation. Further analysis will be done on subsequent generations of plants with modest increases in saturated fatty acid content.
There is no strong evidence for the low palmitate phenotype expected from a co-supressing transformant. In contrast to soybean however, co-supression in canola is a rare transformation event. In our experience with other genes in the fatty acid biosynthetic pathway, as many as 200 transformed lines have been required to observe a strong co-supression phenotype.
| TABLE 11 |
| The relative contribution of 5 fatty acids to the bulk seed fatty acid |
| content in segregating canola plants transformed with pIMC130 containing |
| the canola palmitoyl-ACP thioesterase in the antisense orientation to the |
| Napin promotor |
| FATTY ACID |
| AS % OF TOTAL FATTY ACIDS |
| TRANSFORMANT NO. 16:0 18:0 18:1 18:2 18:3 |
| 130.220 4.0 1.7 65.5 20.1 6.4 |
| 130-527 4.1 1.7 62.6 19.7 10.0 |
| 130-529 4.4 1.7 69.6 17.4 4.6 |
| 130-347 4.0 1.4 64.8 23.3 6.1 |
| 130-738 4.9 1.5 56.6 27.4 7.3 |
| 130-317 4.2 1.4 62.4 22.7 7.6 |
| 130-272 4.8 1.6 62.7 23.2 6.4 |
| 130-412 4.4 3.4 63.7 22.3 6.7 |
| 130-119 3.9 3.3 59.7 25.7 7.9 |
| 130-257 5.0 3.5 62.1 20.5 5.8 |
| 130-677 4.5 1.2 53.6 25.6 10.0 |
| 130-310 4.6 1.6 63.6 23.0 7.3 |
| 130-323 4.0 2.0 67.8 16.9 7.4 |
| 130-699 4.1 1.1 62.5 23.4 6.8 |
| 130-475 5.0 2.0 57.0 23.4 11.0 |
| 130-651 4.4 1.6 66.0 19.2 7.7 |
| 130-126 3.4 1.7 65.4 36.2 8.6 |
| 130-465 5.1 1.9 58.5 24.1 30.0 |
| 130-234 4.2 3.6 64.2 20.9 7.8 |
| 130-661 4.4 3.4 60.6 22.8 9.6 |
| 130-114 4.2 1.4 65.2 19.7 7.5 |
| 130-305 4.6 3.6 58.6 23.9 30.0 |
| 130-240 4.1 1.4 69.1 17.4 6.5 |
| 130-660 4.1 1.4 67.0 18.5 7.2 |
| 130-350 4.1 1.5 62.5 21.1 9.8 |
| 130-36 4.1 1.9 61.4 21.7 8.9 |
| 130-527 4.1 1.5 64.7 19.0 9.0 |
| 130-33 4.0 1.1 62.6 22.1 9.1 |
| westar 4.0 1.7 64.0 19.7 8.5 |
The average palmitic acid content for the 28 transformants analyzed is 4.3 with a standard deviation of the mean of 0.39. While there are no lines which deviate greatly from the mean in bulk seed analysis, line 130-126 is in exess of 2 standard deviations lower than the mean. Since this could be indicative of a weak antisense phenotype observed in a segregating seed population as described above, 12 single seeds from the plant were analyzed for relative fatty acid content along with 12 single seeds from a non-transformed Westar plant grown in the same growth chamber and planted at a comparable date. The results of those analyses are shown in Table 12.
| TABLE 12 |
| FATTY ACID |
| AS % OF TOTAL FATTY ACIDS |
| TRANSFORMANT NO. 16:0 18:0 18:1 18:2 18:3 |
| 130-126 3.07 1.51 67.27 17.26 8.74 |
| 130-126 3.11 1.74 64.70 18.19 9.47 |
| 130-126 3.20 1.66 69.72 16.21 7.40 |
| 130-126 3.47 1.77 69.98 15.66 6.73 |
| 130-126 3.76 2.04 71.26 15.42 5.00 |
| 130-126 3.56 1.80 71.74 15.47 4.83 |
| 130-126 3.11 2.05 65.22 1811 9.37 |
| 130-126 3.45 1.93 71.32 14.72 5.94 |
| 130-126 4.30 1.90 64.97 17.91 8.84 |
| 130-126 2.95 1.93 65.57 17.27 11.11 |
| 130-126 3.44 1.71 69.98 16.06 6.26 |
| 130-126 3.43 1.81 72.40 14.78 5.12 |
| WESTAR4/15 3.81 1.71 62.46 20.46 9.71 |
| WESTAR4/8 4.28 1.42 63.27 20.86 8.30 |
| WESTAR4/8 4.00 1.55 68.80 18.08 5.30 |
| WESTAR4/8 4.19 1.97 61.51 20.01 10.40 |
| WFSTAR4/8 4.37 1.60 63.92 20.02 7.96 |
| WESTAR4/8 4.41 1.45 62.95 20.39 8.36 |
| WESTAR4/8 4.12 1.84 60.90 21.19 11.00 |
| WESTAR4/8 3.89 1.69 63.63 19.68 8.99 |
| WESTAR4/8 3.97 1.73 67.68 17.57 6.43 |
| WESTAR4/8 3.97 1.78 63.78 19.47 8.94 |
| WESTAR4/8 3.85 1.76 64.85 18.56 8.65 |
| WESTAR4/8 4.06 1.69 63.74 20.16 8.52 |
The mean relative palmitic acid content of the 12 seeds from transformant 130-126 is 3.42% and the standard deviation of the mean is 0.359, while the mean palmitic acid content of the 12 control seeds is 4.08 with a standard deviation of the mean of 0.20. The lower mean, greater standard deviation and wider range of observed palmitic acid contents are all indicative of a segregating population in which the seeds homozygous for the antisense transgene for the canola palmitoyl-ACP thioesterase produce slightly less palmitic acid. The observed phenotype will be confirmed by analysis of bulk seeds from multiple plants in the next generation.
As stated for the sense construction above, the occurrence of maximally altered fatty acid phenotypes are rare transformation events in canola. Thus, the phenotype of the low palmitate segregating seed in transformant 130-126 is indicative that the antisense under expression of palmitoyl-ACP thioesterase in canola seeds is capable of decreasing the production of saturated fatty acids but does not indicate the minimum palmitic acid content which may be achieved by this method.
| SEQUENCE LISTING |
| (1) GENERAL INFORMATION: |
| (iii) NUMBER OF SEQUENCES: 32 |
| (2) INFORMATION FOR SEQ ID NO: 1: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1688 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1 |
| ACAATTACAC TGTCTCTCTC TTTTCCAAAA TTAGGGAAAC AACAAGGACG CAAAATGACA 60 |
| CAATAGCCCT TCTTCCCTGT TTCCAGCTTT TCTCCTTCTC TCTCTCTCCA TCTTCTTCTT 120 |
| CTTCTTCACT CAGTCAGATC CAACTCCTCA GATAACACAA GACCAAACCC GCTTTTTCTG 180 |
| CATTTCTAGA CTAGACGTTC TACCGGAGAA GCGACCTTAG AAATTCATTA TGGTGGCAAC 240 |
| AGCTGCTACT TCATCATTTT TCCCTGTTAC TTCACCCTCG CCGGACTCTG GTGGAGCAGG 300 |
| CAGCAAACTT GGTGGTGGGC CTGCAAACCT TGGAGGACTA AAATCCAAAT CTGCGTCTTC 360 |
| TGGTGGCTTG AAGGCAAAGG CGCAAGCCCC TTCGAAAATT AATGGAACCA CAGTTGTTAC 420 |
| ATCTAAAGAA AGCTTCAAGC ATGATGATGA TCTACCTTCG CCTCCCCCCA GAACTTTTAT 480 |
| CAACCAGTTG CCTGATTGGA GCATGCTTCT TGCTGCTATC ACAACAATTT TCTTGGCCGC 540 |
| TGAAAAGCAG TGGATGATGC TTGATTGGAA GCCACGGCGA CCTGACATGC TTATTGACCC 600 |
| CTTTGGGATA GGAAAAATTG TTCAGGATGG TCTTGTGTTC CGTGAAAACT TTTCTATTAG 660 |
| ATCATATGAG ATTGGTGCTG ATCGTACCGC ATCTATAGAA ACAGTAATGA ACCATTTGCA 720 |
| AGAAACTGCA CTTAATCATG TTAAAAGTGC TGGGCTTCTT GGTGATGGCT TTGGTTCCAC 780 |
| GCCAGAAATG TGCAAAAAGA ACTTGATATG GGTGGTTACT CGGATGCAGG TTGTGGTGGA 840 |
| ACGCTATCCT ACATGGGGTG ACATAGTTCA AGTGGACACT TGGGTTTCTG GATCAGGGAA 900 |
| GAATGGTATG CGTCGTGATT GGCTTTTACG TGACTCCAAA ACTGGTGAAA TCTTGACAAG 960 |
| AGCTTCCAGT GTTTGGGTCA TGATGAATAA GCTAACACGG AGGCTGTCTA AAATTCCAGA 1020 |
| AGAAGTCAGA CAGGAGATAG GATCTTATTT TGTGGATTCT GATCCAATTC TGGAAGAGGA 1080 |
| TAACAGAAAA CTGACTAAAC TTGACGACAA CACAGCGGAT TATATTCGTA CCGGTTTAAG 1140 |
| TCCTAGGTGG AGTGATCTAG ATATCAATCA GCATGTCAAC AATGTGAAGT ACATTGGCTG 1200 |
| GATTCTGGAG AGTGCTCCAC AGCCAATCTT GGAGAGTCAT GAGCTTTCTT CCATGACTTT 1260 |
| AGAGTATAGG AGAGAGTGTG GTAGGGACAG TGTGCTGGAT TCCCTGACTG CTGTATCTGG 1320 |
| GGCCGACATG GGCAATCTAG CTCACAGCGG GCATGTTGAG TGCAAGCATT TGCTTCGACT 1380 |
| GGAAAATGGT GCTGAGATTG TGAGGGGCAG GACTGAGTGG AGGCCCAAAC CTGTGAACAA 1440 |
| CTTTGGTGTT GTGAACCAGG TTCCAGCAGA AAGCACCTAA GATTTGAAAT GGTTAACGAT 1500 |
| TGGAGTTGCA TCAGTCTCCT TGCTATGTTT AGACTTATTC TGGTTCCCTG GGGAGAGTTT 1560 |
| TGCTTGTGTC TATCCAATCA ATCTACATGT CTTTAAATAT ATACACCTTC TAATTTGTGA 1620 |
| TACTTTGGTG GGTAAGGGGG AAAAGCAGCA GTAAATCTCA TTCTCATTGT AATTAAAAAA 1680 |
| AAAAAAAA 1688 |
| (2) INFORMATION FOR SEQ ID NO: 2: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1483 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2 |
| GGCACGAGCT CATTCTTCCC TCTCCCATCT TCCCCACTCG ACCCCACCGC AAAAACCAAC 60 |
| AAAGTCACCA CCTCCACCAA CTTCTCCGGC ATCTTCCCCA CTCCAAACTC CTCCGGCAGA 120 |
| TGAAGGTTAA ACCAAACGCT CAGGCCCCAC CCAAGATCAA CGGCAAGAGA GTCGGTCTCC 180 |
| CTTCTGGCTC GGTGAAGCCT GATAACGAGA CGTCCTCACA GCATCCCGCA GCACCGAGGA 240 |
| CGTTCATCAA CCAGCTGCCT GACTGGAGCA TGCTTCTTGC TGCAATAACA ACCGTCTTCT 300 |
| TGGCGGCTGA GAAGCAGTGG ATGATGCTTG ACTGGAAACC GAGGCGCTCT GACGTGATTA 360 |
| TGGATCCGTT TGGGTTAGGG AGGATCGTTC AGGATGGGCT TGTGTTCCGT CAGAATTTCT 420 |
| CTATTCGGTC TTATGAGATA GGTGCTGATC GCTCTGCGTC TATAGAAACG GTTATGAATC 480 |
| ATTTACAGGA AACGGCACTA AACCATGTTA AGACTGCTGG ACTGCTTGGA GATGGGTTTG 540 |
| GTTCTACTCC TGAGATGGTT AAGAAGAACT TGATTTGGGT TGTTACTCGT ATGCAGGTTG 600 |
| TCGTTGATAA ATATCCTACT TGGGGAGATG TTGTGGAAGT AGATACATGG GTGAGCCAGT 660 |
| CTGGAAAGAA CGGTATGCGT CGTGATTGGC TAGTTCGAGA TGGCAATACT GGAGAAATTT 720 |
| TAACAAGAGC ATCAAGTGTG TGGGTGATGA TGAATAAACT GACAAGAAGA TTATCAAAGA 780 |
| TTCCTGAAGA GGTTCGAGGG GAGATAGAGC CTTACTTTGT TAATTCTGAC CCAGTCCTTG 840 |
| CCGAGGACAG CAGAAAGTTA ACAAAACTTG ATGACAAGAC TGCTGACTAT GTTCGTTCTG 900 |
| GTCTCACTCC GCGTTGGAGT GACTTGGATG TTAACCAGCA CGTTAACAAT GTGAAGTACA 960 |
| TCGGGTGGAT ACTGGAGAGT GCACCTGTGG GGATGATGGA GAGTCAGAAG CTGAAAAGCA 1020 |
| TGACTCTGGA GTATCGCAGG GAGTGCGGGA GGGACAGTGT GCTTCAGTCC CTCACCGCGG 1080 |
| TTTCGGGCTG CGATATCGGT AGCCTCGGGA CGGCTGGTGA AGTGGAATGT CAGCATCTGC 1140 |
| TCCGTCTCCA GGATGGAGCT GAAGTGGTGA GAGGAAGAAC AGAGTGGAGT TCCAAAACAT 1200 |
| CAACAACAAC TTGGGACATC ACACCGTGAA AAGAATATAG CAAACATGGG TTCTTTGGTT 1260 |
| CGTTTGTAAA ACTATACTAC CTTGCTTGCA ACCACCACTA CTCAAAAACA GTTTGGGCCA 1320 |
| CCTTTGTATA TTTTCTTTGG TTCTTATTTT TTTTCTTCTT GGAGGTCCCT TTTTATTATA 1380 |
| TTTATTTTTT CTTTTGGGTG CCAGACAAAG GCAAATAACT TTCTTATCCT AATATTATTT 1440 |
| AAATGTATTT TATTTTGGGG GTTTAAAAAA AAAAAAAAAA AAA 1483 |
| (2) INFORMATION FOR SEQ ID NO: 3: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3 |
| CATGGAGGAG CAG 13 |
| (2) INFORMATION FOR SEQ ID NO: 4: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 9 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4 |
| CTGCTCCTC 9 |
| (2) INFORMATION FOR SEQ ID NO: 5: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5 |
| AAGGAAAAAA GCGGCCGCTG ACACAATAGC CCTTCT 36 |
| (2) INFORMATION FOR SEQ ID NO: 6: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 328 amino acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: unknown |
| (D) TOPOLOGY: unknown |
| (ii) MOLECULE TYPE: protein |
| (iii) HYPOTHETICAL: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6 |
| Met Glu Glu Gln Leu Pro Asp Trp Ser Met Leu Leu Ala Ala Ile Thr |
| 1 5 10 15 |
| Thr Val Phe Leu Ala Ala Glu Lys Gln Trp Met Met Leu Asp Trp Lys |
| 20 25 30 |
| Pro Arg Arg Ser Asp Val Ile Met Asp Pro Phe Gly Leu Gly Arg Ile |
| 35 40 45 |
| Val Gln Asp Gly Leu Val Phe Arg Gln Asn Phe Ser Ile Arg Ser Tyr |
| 50 55 60 |
| Glu Ile Gly Ala Asp Arg Ser Ala Ser Ile Glu Thr Val Met Asn His |
| 65 70 75 80 |
| Leu Gln Glu Thr Ala Leu Asn His Val Lys Thr Ala Gly Leu Leu Gly |
| 85 90 95 |
| Asp Gly Phe Gly Ser Thr Pro Glu Met Val Lys Lys Asn Leu Ile Trp |
| 100 105 110 |
| Val Val Thr Arg Met Gln Val Val Val Asp Lys Tyr Pro Thr Trp Gly |
| 115 120 125 |
| Asp Val Val Glu Val Asp Thr Trp Val Ser Gln Ser Gly Lys Asn Gly |
| 130 135 140 |
| Met Arg Arg Asp Trp Leu Val Arg Asp Gly Asn Thr Gly Glu Ile Leu |
| 145 150 155 160 |
| Thr Arg Ala Ser Ser Val Trp Val Met Met Asn Lys Leu Thr Arg Arg |
| 165 170 175 |
| Leu Ser Lys Ile Pro Glu Glu Val Arg Gly Glu Ile Glu Pro Tyr Phe |
| 180 185 190 |
| Val Asn Ser Asp Pro Val Leu Ala Glu Asp Ser Arg Lys Leu Thr Lys |
| 195 200 205 |
| Leu Asp Asp Lys Thr Ala Asp Tyr Val Arg Ser Gly Leu Thr Pro Arg |
| 210 215 220 |
| Trp Ser Asp Leu Asp Val Asn Gln His Val Asn Asn Val Lys Tyr Ile |
| 225 230 235 240 |
| Gly Trp Ile Leu Glu Ser Ala Pro Val Gly Met Met Glu Ser Gln Lys |
| 245 250 255 |
| Leu Lys Ser Met Thr Leu Glu Tyr Arg Arg Glu Cys Gly Arg Asp Ser |
| 260 265 270 |
| Val Leu Gln Ser Leu Thr Ala Val Ser Gly Cys Asp Ile Gly Ser Leu |
| 275 280 285 |
| Gly Thr Ala Gly Glu Val Glu Cys Gln His Leu Leu Arg Leu Gln Asp |
| 290 295 300 |
| Gly Ala Glu Val Val Arg Gly Arg Thr Glu Trp Ser Ser Lys Thr Ser |
| 305 310 315 320 |
| Thr Thr Thr Trp Asp Ile Thr Pro |
| 325 |
| (2) INFORMATION FOR SEQ ID NO: 7: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 328 amino acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: unknown |
| (D) TOPOLOGY: unknown |
| (ii) MOLECULE TYPE: protein |
| (iii) HYPOTHETICAL: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7 |
| Met Glu Glu Gln Leu Leu Ala Ala Ile Thr Thr Ile Phe Leu Ala Ala |
| 1 5 10 15 |
| Glu Lys Gln Trp Met Met Leu Asp Trp Lys Pro Arg Arg Pro Asp Met |
| 20 25 30 |
| Leu Ile Asp Pro Phe Gly Ile Gly Lys Ile Val Gln Asp Gly Leu Val |
| 35 40 45 |
| Phe Arg Glu Asn Phe Ser Ile Arg Ser Tyr Glu Ile Gly Ala Asp Arg |
| 50 55 60 |
| Thr Ala Ser Ile Glu Thr Val Met Asn His Leu Gln Glu Thr Ala Leu |
| 65 70 75 80 |
| Asn His Val Lys Ser Ala Gly Leu Leu Gly Asp Gly Phe Gly Ser Thr |
| 85 90 95 |
| Pro Glu Met Cys Lys Lys Asn Leu Ile Trp Val Val Thr Arg Met Gln |
| 100 105 110 |
| Val Val Val Glu Arg Tyr Pro Thr Trp Gly Asp Ile Val Gln Val Asp |
| 115 120 125 |
| Thr Trp Val Ser Gly Ser Gly Lys Asn Gly Met Arg Arg Asp Trp Leu |
| 130 135 140 |
| Leu Arg Asp Ser Lys Thr Gly Glu Ile Leu Thr Arg Ala Ser Ser Val |
| 145 150 155 160 |
| Trp Val Met Met Asn Lys Leu Thr Arg Arg Leu Ser Lys Ile Pro Glu |
| 165 170 175 |
| Glu Val Arg Gln Glu Ile Gly Ser Tyr Phe Val Asp Ser Asp Pro Ile |
| 180 185 190 |
| Leu Glu Glu Asp Asn Arg Lys Leu Thr Lys Leu Asp Asp Asn Thr Ala |
| 195 200 205 |
| Asp Tyr Ile Arg Thr Gly Leu Ser Pro Arg Trp Ser Asp Leu Asp Ile |
| 210 215 220 |
| Asn Gln His Val Asn Asn Val Lys Tyr Ile Gly Trp Ile Leu Glu Ser |
| 225 230 235 240 |
| Ala Pro Gln Pro Ile Leu Glu Ser His Glu Leu Ser Ser Met Thr Leu |
| 245 250 255 |
| Glu Tyr Arg Arg Glu Cys Gly Arg Asp Ser Val Leu Asp Ser Leu Thr |
| 260 265 270 |
| Ala Val Ser Gly Ala Asp Met Gly Asn Leu Ala His Ser Gly His Val |
| 275 280 285 |
| Glu Cys Lys His Leu Leu Arg Leu Glu Asn Gly Ala Glu Ile Val Arg |
| 290 295 300 |
| Gly Arg Thr Glu Trp Arg Pro Lys Pro Val Asn Asn Phe Gly Val Val |
| 305 310 315 320 |
| Asn Gln Val Pro Ala Glu Ser Thr |
| 325 |
| (2) INFORMATION FOR SEQ ID NO: 8: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1174 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8 |
| ATAGGAGGTG GGAGAATGGG TATAGAATAA CATCAATGGC AGCAACTGCG GATCAAGCAG 60 |
| CTTTCATATT AAGCATACCA AAGCGTAAGA TGGTGGATGA AACTCAAGAG ACTCTCCGCA 120 |
| CCACCGCCTT TCCAAGTACT CATGTCAAGG TTGGTTTCTT TAGCTTTGAA CACAGATTTG 180 |
| GATCTTTTTG TTTTGTTTCC ATATACTTAG GACCTGAGAG CTTTTGGTTG ATTTTTTTTT 240 |
| CAGGACAAAT GGGCGAAGAA TCTGTACATT GCATCAATAT GCTATGGCAG GACAGTGTGC 300 |
| TGATACACAC TTAAGCATCA TGTGGAAAGC CAAAGACAAT TGGAGCGAGA CTCAGGGTCG 360 |
| TCATAATACC AATCAAAGAC GTAAAACCAG ACGCAACCTC TTTGGTTGAA TGTAATGAAA 420 |
| GGGATGTGTC TTGGTATGTA TGTACGAATA ACAAAAGAGA AGATGGAATT AGTAGTAGAA 480 |
| AATATTTGGG AGCTTTTTAA GCCCTTCAAG TGTGCTTTTT ATCTTATTGA TATCATCCAT 540 |
| TTGCGTTGTT TAATGCGTCT CTAGATATGT TCCTATATCT TTCTCAGTGT CTGATAAGTG 600 |
| AAATGTGAGA AAACCATACC AAACCAAAAT ATTCAAATCT TATTTTTAAT AATGTTGAAT 660 |
| CACTCGGAGT TGCCACCTTC TGTGCCAATT GTGCTGAATC TATCACACTA GAAAAAAACA 720 |
| TTTCTTCAAG GTAATGACTT GTGGACTATG TTCTGAATTC TCATTAAGTT TTTATTTTCT 780 |
| GAAGTTTAAG TTTTTACCTT CTGTTTTGAA ATATATCGTT CATAAGATGT CACGCCAGGA 840 |
| CATGAGCTAC ACATCGCACA TAGCATGCAG ATCAGGACGA TTTGTCACTC ACTTCAAACA 900 |
| CCTAAGAGCT TCTCTCTCAC AGCGCACACA CATATGCATG CAATATTTAC ACGTGATCGC 960 |
| CATGCAAATC TCCATTCTCA CCTATAAATT AGAGCCTCGG CTTCACTCTT TACTCAAACC 1020 |
| AAAACTCATC ACTACAGAAC ATACACAAAT GGCGAACAAG CTCTTCCTCG TCTCGGCAAC 1080 |
| TCTCGCCTTG TTCTTCCTTC TCACCAATGC CTCCGTCTAC AGGACGGTTG TGGAAGTCGA 1140 |
| CGAAGATGAT GCCACAAATC CAGCCGGCCC ATTT 1174 |
| (2) INFORMATION FOR SEQ ID NO: 9: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1174 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9 |
| TATCCTCCAC CCTCTTACCC ATATCTTATT GTAGTTACCG TCGTTGACGC CTAGTTCGTC 60 |
| GAAAGTATAA TTCGTATGGT TTCGCATTCT ACCACCTACT TTGAGTTCTC TGAGAGGCGT 120 |
| GGTGGCGGAA AGGTTCATGA GTACAGTTCC AACCAAAGAA ATCGAAACTT GTGTCTAAAC 180 |
| CTAGAAAAAC AAAACAAAGG TATATGAATC CTGGACTCTC GAAAACCAAC TAAAAAAAAA 240 |
| GTCCTGTTTA CCCGCTTCTT AGACATGTAA CGTAGTTATA CGATACCGTC CTGTCACACG 300 |
| ACTATGTGTG AATTCGTAGT ACACCTTTCG GTTTCTGTTA ACCTCGCTCT GAGTCCCAGC 360 |
| AGTATTATGG TTAGTTTCTG CATTTTGGTC TGCGTTGGAG AAACCAACTT ACATTACTTT 420 |
| CCCTACACAG AACCATACAT ACATGCTTAT TGTTTTCTCT TCTACCTTAA TCATCATCTT 480 |
| TTATAAACCC TCGAAAAATT CGGGAAGTTC ACACGAAAAA TAGAATAACT ATAGTAGGTA 540 |
| AACGCAACAA ATTACGCAGA GATCTATACA AGGATATAGA AAGAGTCACA GACTATTCAC 600 |
| TTTACACTCT TTTGGTATGG TTTGGTTTTA TAAGTTTAGA ATAAAAATTA TTACAACTTA 660 |
| GTGAGCCTCA ACGGTGGAAG ACACGGTTAA CACGACTTAG ATAGTGTGAT CTTTTTTTGT 720 |
| AAAGAAGTTC CATTACTGAA CACCTGATAC AAGACTTAAG AGTAATTCAA AAATAAAAGA 780 |
| CTTCAAATTC AAAAATGGAA GACAAAACTT TATATAGCAA GTATTCTACA GTGCGGTCCT 840 |
| GTACTCGATG TGTAGCGTGT ATCGTACGTC TAGTCCTGCT AAACAGTGAG TGAAGTTTGT 900 |
| GGATTCTCGA AGAGAGAGTG TCGCGTGTGT GTATACGTAC GTTATAAATG TGCACTAGCG 960 |
| GTACGTTTAG AGGTAAGAGT GGATATTTAA TCTCGGAGCC GAAGTGAGAA ATGAGTTTGG 1020 |
| TTTTGAGTAG TGATGTCTTG TATGTGTTTA CCGCTTGTTC GAGAAGGAGC AGAGCCGTTG 1080 |
| AGAGCGGAAC AAGAAGGAAG AGTGGTTACG GAGGCAGATG TCCTGCCAAC ACCTTCAGCT 1140 |
| GCTTCTACTA CGGTGTTTAG GTCGGCCGGG TAAA 1174 |
| (2) INFORMATION FOR SEQ ID NO: 10: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1303 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10 |
| ACGCACTTAC CTAGAGCTTG CAACATCAGG CAAGTTAGCA TTTGCCCCTT CCAGAAGACC 60 |
| ATGCCTGGGC CCGGCTTCTA CTAGATTCCA AACGAATATC CTCGAGAGTG TGTATACCAC 120 |
| GGTGATATGA GTGTGGTTGT TGATGTATGT TAACACTACA TAGTCATGGT GTGTGTTCCA 180 |
| TAAATAATGT ACTAATGTAA TAAGAACTAC TCCGTAGACG GTAATAAAAG AGAAGTTTTT 240 |
| TTTTTTTACT CTTGCTACTT TCCTATAAAG TGATGATTAA CAACAGATAC ACCAAAAAGA 300 |
| AAACAATTAA TCTATATTCA CAATGAAGCA GTACTAGTCT ATTGAACATG TCAGATTTTC 360 |
| TTTTTCTAAA TGTCTAATTA AGCCTTCAAG GCTAGTGATG ATAAAAGATC ATCCAATGGG 420 |
| ATCCAACAAA GACTCAAATC TGGTTTTGAT CAGATACTTC AAAACTATTT TTGTATTCAT 480 |
| TAAATTATGC AAGTGTTCTT TTATTTGGTG AAGACTCTTT AGAAGCAAAG AACGACAAGC 540 |
| AGTAATAAAA AAAACAAAGT TCAGTTTTAA GATTTGTTAT TGACTTATTG TCATTTGAAA 600 |
| AATATAGTAT GATATTAATA TAGTTTTATT TATATAATGC TTGTCTATTC AAGATTTGAG 660 |
| AACATTAATA TGATACTGTC CACATATCCA ATATATTAAG TTTCATTTCT GTTCAAACAT 720 |
| ATGATAAGAT GGTCAAATGA TTATGAGTTT TGTTATTTAC CTGAAGAAAA GATAAGTGAG 780 |
| CTTCGAGTTT CTGAAGGGTA CGTGATCTTC ATTTCTTGGC TAAAAGCGAA TATGACATCA 840 |
| CCTAGAGAAA GCCGATAATA GTAAACTCTG TTCTTGGTTT TTGGTTTAAT CAAACCGAAC 900 |
| CGGTAGCTGA GTGTCAAGTC AGCAAACATC GCAAACCATA TGTCAATTCG TTAGATTCCC 960 |
| GGTTTAAGTT GTAAACCGGT ATTTCATTTG GTGAAAACCC TAGAAGCCAG CCACCTTTTT 1020 |
| AATCTAATTT TTGCAAACGA GAAGTCACCA CACCTCTCCA CTAAAACCCT GAACCTTACT 1080 |
| GAGAGAAGCA GAGCAAAAGA ACAAATAAAA CCCGAAGATG AGACCACCAC GTGCGGCGGG 1140 |
| ACGTTCAGGG GACGGGGAGG AAGAGAATGC GGCGGTTTGG TGGCGGCGGC GGACGTTTGG 1200 |
| TGGCGGCGGT GGACGTTTTG GTGGCGGCGG TGGACCTTTG GTGGTGGATA TCGTGACGAA 1260 |
| GGACCTCCCA GTGAAGTCAT TGGTTCGTTT ACTCTTTTCT TAG 1303 |
| (2) INFORMATION FOR SEQ ID NO: 11: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1303 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11 |
| TGCGTGAATG GATCTCGAAC GTTGTAGTCC GTTCAATCGT AAACGGGGAA GGTCTTCTGG 60 |
| TACGGACCCG GGCCGAAGAT GATCTAAGGT TTGCTTATAG GAGCTCTCAC ACATATGGTG 120 |
| CCACTATACT CACACCAACA ACTACATACA ATTGTGATGT ATCAGTACCA CACACAAGGT 180 |
| ATTTATTACA TGATTACATT ATTCTTGATG AGGCATCTGC CATTATTTTC TCTTCAAAAA 240 |
| AAAAAAATGA GAACGATGAA AGGATATTTC ACTACTAATT GTTGTCTATG TGGTTTTTCT 300 |
| TTTGTTAATT AGATATAAGT GTTACTTCGT CATGATCAGA TAACTTGTAC AGTCTAAAAG 360 |
| AAAAAGATTT ACAGATTAAT TCGGAAGTTC CGATCACTAC TATTTTCTAG TAGGTTACCC 420 |
| TAGGTTGTTT CTGAGTTTAG ACCAAAACTA GTCTATGAAG TTTTGATAAA AACATAAGTA 480 |
| ATTTAATACG TTCACAAGAA AATAAACCAC TTCTGAGAAA TCTTCGTTTC TTGCTGTTCG 540 |
| TCATTATTTT TTTTGTTTCA AGTCAAAATT CTAAACAATA ACTGAATAAC AGTAAACTTT 600 |
| TTATATCATA CTATAATTAT ATCAAAATAA ATATATTACG AACAGATAAG TTCTAAACTC 660 |
| TTGTAATTAT ACTATGACAG GTGTATAGGT TATATAATTC AAAGTAAAGA CAAGTTTGTA 720 |
| TACTATTCTA CCAGTTTACT AATACTCAAA ACAATAAATG GACTTCTTTT CTATTCACTC 780 |
| GAAGCTCAAA GACTTCCCAT GCACTAGAAG TAAAGAACCG ATTTTCGCTT ATACTGTAGT 840 |
| GGATCTCTTT CGGCTATTAT CATTTGAGAC AAGAACCAAA AACCAAATTA GTTTGGCTTG 900 |
| GCCATCGACT CACAGTTCAG TCGTTTGTAG CGTTTGGTAT ACAGTTAAGC AATCTAAGGG 960 |
| CCAAATTCAA CATTTGGCCA TAAAGTAAAC CACTTTTGGG ATCTTCGGTC GGTGGAAAAA 1020 |
| TTAGATTAAA AACGTTTGCT CTTCAGTGGT GTGGAGAGGT GATTTTGGGA CTTGGAATGA 1080 |
| CTCTCTTCGT CTCGTTTTCT TGTTTATTTT GGGCTTCTAC TCTGGTGGTG CACGCCGCCC 1140 |
| TGCAAGTCCC CTGCCCCTCC TTCTCTTACG CCGCCAAACC ACCGCCGCCG CCTGCAAACC 1200 |
| ACCGCCGCCA CCTGCAAAAC CACCGCCGCC ACCTGGAAAC CACCACCTAT AGCACTGCTT 1260 |
| CCTGGAGGGT CACTTCAGTA ACCAAGCAAA TGAGAAAAGA ATC 1303 |
| (2) INFORMATION FOR SEQ ID NO: 12: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12 |
| AAGGAAAAAA GCGGCCGCGA TTTACTGCTG CTTTTC 36 |
| (2) INFORMATION FOR SEQ ID NO: 13: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 24 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13 |
| AACATCAATG GCAGCAACTG CGGA 24 |
| (2) INFORMATION FOR SEQ ID NO: 14: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 23 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14 |
| GCCGGCTGGA TTTGTGGCAT CAT 23 |
| (2) INFORMATION FOR SEQ ID NO: 15: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15 |
| CTAGATCTCC ATGGGTGTAT GTTCTGTAGT GATG 34 |
| (2) INFORMATION FOR SEQ ID NO: 16: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16 |
| TCAGGCCTGT CGACCTGCGG ATCAAGCAGC TTTCA 35 |
| (2) INFORMATION FOR SEQ ID NO: 17: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17 |
| CTAGATCTGG TACCTAGATT CCAAACGAAA TCCT 34 |
| (2) INFORMATION FOR SEQ ID NO: 18: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 24 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18 |
| AACATCAGGC AAGTTAGCAT TTGC 24 |
| (2) INFORMATION FOR SEQ ID NO: 19: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19 |
| TCAGGCCTGT CGACGAGGTC CTTCGTCAGC ATAT 34 |
| (2) INFORMATION FOR SEQ ID NO: 20: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 24 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20 |
| AACGAACCAA TGACTTCACT GGGA 24 |
| (2) INFORMATION FOR SEQ ID NO: 21: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21 |
| CCATGGGAGC TCGTCGACGA GGTCCTTCGT CACGAT 36 |
| (2) INFORMATION FOR SEQ ID NO: 22: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22 |
| GAGCTCCCAT GGAGATCTGG TACCTAGATT CCAAAC 36 |
| (2) INFORMATION FOR SEQ ID NO: 23: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 20 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23 |
| GACTATGTTC TGAATTCTCA 20 |
| (2) INFORMATION FOR SEQ ID NO: 24: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 39 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24 |
| GACAAGATCT GCGGCCGCTA AAGAGTGAAG CCGAGGCTC 39 |
| (2) INFORMATION FOR SEQ ID NO: 25: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 10 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25 |
| GTCGACGAGG 10 |
| (2) INFORMATION FOR SEQ ID NO: 26: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 12 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26 |
| AGATCTGGTA CC 12 |
| (2) INFORMATION FOR SEQ ID NO: 27: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1688 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: YES |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27 |
| TTTTTTTTTT TTTTAATTAC AATGAGAATG AGATTTACTG CTGCTTTTCC CCCTTACCCA 60 |
| CCAAAGTATC ACAAATTAGA AGGTGTATAT ATTTAAAGAC ATGTAGATTG ATTGGATAGA 120 |
| CACAAGCAAA ACTCTCCCCA GGGAACCAGA ATAAGTCTAA ACATAGCAAG GAGACTGATG 180 |
| CAACTCCAAT CGTTAACCAT TTCAAATCTT AGGTGCTTTC TGCTGGAACC TGGTTCACAA 240 |
| CACCAAAGTT GTTCACAGGT TTGGGCCTCC ACTCAGTCCT GCCCCTCACA ATCTCAGCAC 300 |
| CATTTTCCAG TCGAAGCAAA TGCTTGCACT CAACATGCCC GCTGTGAGCT AGATTGCCCA 360 |
| TGTCGGCCCC AGATACAGCA GTCAGGGAAT CCAGCACACT GTCCCTACCA CACTCTCTCC 420 |
| TATACTCTAA AGTCATGGAA GAAAGCTCAT GACTCTCCAA GATTGGCTGT GGAGCACTCT 480 |
| CCAGAATCCA GCCAATGTAC TTCACATTGT TGACATGCTG ATTGATATCT AGATCACTCC 540 |
| ACCTAGGACT TAAACCGGTA CGAATATAAT CCGCTGTGTT GTCGTCAAGT TTAGTCAGTT 600 |
| TTCTGTTATC CTCTTCCAGA ATTGGATCAG AATCCACAAA ATAAGATCCT ATCTCCTGTC 660 |
| TGACTTCTTC TGGAATTTTA GACAGCCTCC GTGTTAGCTT ATTCATCATG ACCCAAACAC 720 |
| TGGAAGCTCT TGTCAAGATT TCACCAGTTT TGGAGTCACG TAAAAGCCAA TCACGACGCA 780 |
| TACCATTCTT CCCTGATCCA GAAACCCAAG TGTCCACTTG AACTATGTCA CCCCATGTAG 840 |
| GATAGCGTTC CACCACAACC TGCATCCGAG TAACCACCCA TATCAAGTTC TTTTTGCACA 900 |
| TTTCTGGCGT GGAACCAAAG CCATCACCAA GAAGCCCAGC ACTTTTAACA TGATTAAGTG 960 |
| CAGTTTCTTG CAAATGGTTC ATTACTGTTT CTATAGATGC GGTACGATCA GCACCAATCT 1020 |
| CATATGATCT AATAGAAAAG TTTTCACGGA ACACAAGACC ATCCTGAACA ATTTTTCCTA 1080 |
| TCCCAAAGGG GTCAATAAGC ATGTCAGGTC GCCGTGGCTT CCAATCAAGC ATCATCCACT 1140 |
| GCTTTTCAGC GGCCAAGAAA ATTGTTGTGA TAGCAGCAAG AAGCATGCTC CAATCAGGCA 1200 |
| ACTGGTTGAT AAAAGTTCTG GGGGGAGGCG AAGGTAGATC ATCATCATGC TTGAAGCTTT 1260 |
| CTTTAGATGT AACAACTGTG GTTCCATTAA TTTTCGAAGG GGCTTGCGCC TTTGCCTTCA 1320 |
| AGCCACCAGA AGACGCAGAT TTGGATTTTA GTCCTCCAAG GTTTGCAGGC CCACCACCAA 1380 |
| GTTTGCTGCC TGCTCCACCA GAGTCCGGCG AGGGTGAAGT AACAGGGAAA AATGATGAAG 1440 |
| TAGCAGCTGT TGCCACCATA ATGAATTTCT AAGGTCGCTT CTCCGGTAGA ACGTCTAGTC 1500 |
| TAGAAATGCA GAAAAAGCGG GTTTGGTCTT GTGTTATCTG AGGAGTTGGA TCTGACTGAG 1560 |
| TGAAGAAGAA GAAGAAGATG GAGAGAGAGA GAAGGAGAAA AGCTGGAAAC AGGGAAGAAG 1620 |
| GGCTATTGTG TCATTTTGCG TCCTTGTTGT TTCCCTAATT TTGGAAAAGA GAGAGACAGT 1680 |
| GTAATTGT 1688 |
| (2) INFORMATION FOR SEQ ID NO: 28: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1483 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (iv) ANTI-SENSE: YES |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28 |
| TTTTTTTTTT TTTTTTTTTA AACCCCCAAA ATAAAATACA TTTAAATAAT ATTAGGATAA 60 |
| GAAAGTTATT TGCCTTTGTC TGGCACCCAA AAGAAAAAAT AAATATAATA AAAAGGGACC 120 |
| TCCAAGAAGA AAAAAAATAA GAACCAAAGA AAATATACAA AGGTGGCCCA AACTGTTTTT 180 |
| GAGTAGTGGT GGTTGCAAGC AAGGTAGTAT AGTTTTACAA ACGAACCAAA GAACCCATGT 240 |
| TTGCTATATT CTTTTCACGG TGTGATGTCC CAAGTTGTTG TTGATGTTTT GGAACTCCAC 300 |
| TCTGTTCTTC CTCTCACCAC TTCAGCTCCA TCCTGGAGAC GGAGCAGATG CTGACATTCC 360 |
| ACTTCACCAG CCGTCCCGAG GCTACCGATA TCGCAGCCCG AAACCGCGGT GAGGGACTGA 420 |
| AGCACACTGT CCCTCCCGCA CTCCCTGCGA TACTCCAGAG TCATGCTTTT CAGCTTCTGA 480 |
| CTCTCCATCA TCCCCACAGG TGCACTCTCC AGTATCCACC CGATGTACTT CACATTGTTA 540 |
| ACGTGCTGGT TAACATCCAA GTCACTCCAA CGCGGAGTGA GACCAGAACG AACATAGTCA 600 |
| GCAGTCTTGT CATCAAGTTT TGTTAACTTT CTGCTGTCCT CGGCAAGGAC TGGGTCAGAA 660 |
| TTAACAAAGT AAGGCTCTAT CTCCCCTCGA ACCTCTTCAG GAATCTTTGA TAATCTTCTT 720 |
| GTCAGTTTAT TCATCATCAC CCACACACTT GATGCTCTTG TTAAAATTTC TCCAGTATTG 780 |
| CCATCTCGAA CTAGCCAATC ACGACGCATA CCGTTCTTTC CAGACTGGCT CACCCATGTA 840 |
| TCTACTTCCA CAACATCTCC CCAAGTAGGA TATTTATCAA CGACAACCTG CATACGAGTA 900 |
| ACAACCCAAA TCAAGTTCTT CTTAACCATC TCAGGAGTAG AACCAAACCC ATCTCCAAGC 960 |
| AGTCCAGCAG TCTTAACATG GTTTAGTGCC GTTTCCTGTA AATGATTCAT AACCGTTTCT 1020 |
| ATAGACGCAG AGCGATCAGC ACCTATCTCA TAAGACCGAA TAGAGAAATT CTGACGGAAC 1080 |
| ACAAGCCCAT CCTGAACGAT CCTCCCTAAC CCAAACGGAT CCATAATCAC GTCAGAGCGC 1140 |
| CTCGGTTTCC AGTCAAGCAT CATCCACTGC TTCTCAGCCG CCAAGAAGAC GGTTGTTATT 1200 |
| GCAGCAAGAA GCATGCTCCA GTCAGGCAGC TGGTTGATGA ACGTCCTCGG TGCTGCGGGA 1260 |
| TGCTGTGAGG ACGTCTCGTT ATCAGGCTTC ACCGAGCCAG AAGGGAGACC GACTCTCTTG 1320 |
| CCGTTGATCT TGGGTGGGGC CTGAGCGTTT GGTTTAACCT TCATCTGCCG GAGGAGTTTG 1380 |
| GAGTGGGGAA GATGCCGGAG AAGTTGGTGG AGGTGGTGAC TTTGTTGGTT TTTGCGGTGG 1440 |
| GGTCGAGTGG GGAAGATGGG AGAGGGAAGA ATGAGCTCGT GCC 1483 |
| (2) INFORMATION FOR SEQ ID NO: 29: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 324 amino acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: unknown |
| (D) TOPOLOGY: unknown |
| (ii) MOLECULE TYPE: protein |
| (iii) HYPOTHETICAL: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29 |
| Leu Pro Asp Trp Ser Met Leu Leu Ala Ala Ile Thr Thr Val Phe Leu |
| 1 5 10 15 |
| Ala Ala Glu Lys Gln Trp Met Met Leu Asp Trp Lys Pro Arg Arg Ser |
| 20 25 30 |
| Asp Val Ile Met Asp Pro Phe Gly Leu Gly Arg Ile Val Gln Asp Gly |
| 35 40 45 |
| Leu Val Phe Arg Gln Asn Phe Ser Ile Arg Ser Tyr Glu Ile Gly Ala |
| 50 55 60 |
| Asp Arg Ser Ala Ser Ile Glu Thr Val Met Asn His Leu Gln Glu Thr |
| 65 70 75 80 |
| Ala Leu Asn His Val Lys Thr Ala Gly Leu Leu Gly Asp Gly Phe Gly |
| 85 90 95 |
| Ser Thr Pro Glu Met Val Lys Lys Asn Leu Ile Trp Val Val Thr Arg |
| 100 105 110 |
| Met Gln Val Val Val Asp Lys Tyr Pro Thr Trp Gly Asp Val Val Glu |
| 115 120 125 |
| Val Asp Thr Trp Val Ser Gln Ser Gly Lys Asn Gly Met Arg Arg Asp |
| 130 135 140 |
| Trp Leu Val Arg Asp Gly Asn Thr Gly Glu Ile Leu Thr Arg Ala Ser |
| 145 150 155 160 |
| Ser Val Trp Val Met Met Asn Lys Leu Thr Arg Arg Leu Ser Lys Ile |
| 165 170 175 |
| Pro Glu Glu Val Arg Gly Glu Ile Glu Pro Tyr Phe Val Asn Ser Asp |
| 180 185 190 |
| Pro Val Leu Ala Glu Asp Ser Arg Lys Leu Thr Lys Leu Asp Asp Lys |
| 195 200 205 |
| Thr Ala Asp Tyr Val Arg Ser Gly Leu Thr Pro Arg Trp Ser Asp Leu |
| 210 215 220 |
| Asp Val Asn Gln His Val Asn Asn Val Lys Tyr Ile Gly Trp Ile Leu |
| 225 230 235 240 |
| Glu Ser Ala Pro Val Gly Met Met Glu Ser Gln Lys Leu Lys Ser Met |
| 245 250 255 |
| Thr Leu Glu Tyr Arg Arg Glu Cys Gly Arg Asp Ser Val Leu Gln Ser |
| 260 265 270 |
| Leu Thr Ala Val Ser Gly Cys Asp Ile Gly Ser Leu Gly Thr Ala Gly |
| 275 280 285 |
| Glu Val Glu Cys Gln His Leu Leu Arg Leu Gln Asp Gly Ala Glu Val |
| 290 295 300 |
| Val Arg Gly Arg Thr Glu Trp Ser Ser Lys Thr Ser Thr Thr Thr Trp |
| 305 310 315 320 |
| Asp Ile Thr Pro |
| (2) INFORMATION FOR SEQ ID NO: 30: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 324 amino acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: unknown |
| (D) TOPOLOGY: unknown |
| (ii) MOLECULE TYPE: protein |
| (iii) HYPOTHETICAL: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30 |
| Leu Leu Ala Ala Ile Thr Thr Ile Phe Leu Ala Ala Glu Lys Gln Trp |
| 1 5 10 15 |
| Met Met Leu Asp Trp Lys Pro Arg Arg Pro Asp Met Leu Ile Asp Pro |
| 20 25 30 |
| Phe Gly Ile Gly Lys Ile Val Gln Asp Gly Leu Val Phe Arg Glu Asn |
| 35 40 45 |
| Phe Ser Ile Arg Ser Tyr Glu Ile Gly Ala Asp Arg Thr Ala Ser Ile |
| 50 55 60 |
| Glu Thr Val Met Asn His Leu Gln Glu Thr Ala Leu Asn His Val Lys |
| 65 70 75 80 |
| Ser Ala Gly Leu Leu Gly Asp Gly Phe Gly Ser Thr Pro Glu Met Cys |
| 85 90 95 |
| Lys Lys Asn Leu Ile Trp Val Val Thr Arg Met Gln Val Val Val Glu |
| 100 105 110 |
| Arg Tyr Pro Thr Trp Gly Asp Ile Val Gln Val Asp Thr Trp Val Ser |
| 115 120 125 |
| Gly Ser Gly Lys Asn Gly Met Arg Arg Asp Trp Leu Leu Arg Asp Ser |
| 130 135 140 |
| Lys Thr Gly Glu Ile Leu Thr Arg Ala Ser Ser Val Trp Val Met Met |
| 145 150 155 160 |
| Asn Lys Leu Thr Arg Arg Leu Ser Lys Ile Pro Glu Glu Val Arg Gln |
| 165 170 175 |
| Glu Ile Gly Ser Tyr Phe Val Asp Ser Asp Pro Ile Leu Glu Glu Asp |
| 180 185 190 |
| Asn Arg Lys Leu Thr Lys Leu Asp Asp Asn Thr Ala Asp Tyr Ile Arg |
| 195 200 205 |
| Thr Gly Leu Ser Pro Arg Trp Ser Asp Leu Asp Ile Asn Gln His Val |
| 210 215 220 |
| Asn Asn Val Lys Tyr Ile Gly Trp Ile Leu Glu Ser Ala Pro Gln Pro |
| 225 230 235 240 |
| Ile Leu Glu Ser His Glu Leu Ser Ser Met Thr Leu Glu Tyr Arg Arg |
| 245 250 255 |
| Glu Cys Gly Arg Asp Ser Val Leu Asp Ser Leu Thr Ala Val Ser Gly |
| 260 265 270 |
| Ala Asp Met Gly Asn Leu Ala His Ser Gly His Val Glu Cys Lys His |
| 275 280 285 |
| Leu Leu Arg Leu Glu Asn Gly Ala Glu Ile Val Arg Gly Arg Thr Glu |
| 290 295 300 |
| Trp Arg Pro Lys Pro Val Asn Asn Phe Gly Val Val Asn Gln Val Pro |
| 305 310 315 320 |
| Ala Glu Ser Thr |
| (2) INFORMATION FOR SEQ ID NO: 31: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 1674 base pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| (ii) MOLECULE TYPE: DNA (genomic) |
| (iii) HYPOTHETICAL: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31 |
| GCACGAGCTC GTGCCGAATT CGGCACGAGC GGCACGAGGA AAATACAGAG AGACAAATTT 60 |
| AAAACAAAAC GAAAGGAGAT CGAGAGAGGA GAGAGGCGCA CACACACACA CACAAAGGAG 120 |
| AACTTTAGGG TTTGGGGAGA CTCCGAAGAG ATTGGCGTAA CACTTCTGTC TTTGAACGCT 180 |
| TATCTTCCTC GTCATGGTGG CTACTTGCGC TACGTCGTCG TTTTTTCATG TTCCATCTTC 240 |
| TTCCTCGCTT GATACGAATG GGAAGGGGAA CAGAGTTGGG TCCACTAATT TTGCTGGACT 300 |
| TAACTCAACG CCAAGCTCTG GGAGGATGAA GGTTAAGCCA AACGCTCAGG CTCCACCCAA 360 |
| GATCAACGGG AAGAAAGCTA ACTTGCCTGG CTCTGTAGAG ATATCAAAGG CTGACAACGA 420 |
| GACTTCGCAG CCCGCACACG CACCGAGGAC GTTTATCAAC CAGCTGCCTG ACTGGAGTAT 480 |
| GCTGCTTGCT GCTATAACTA CCATTTTCTT GGCAGCGGAG AAACAGTGGA TGATGCTTGA 540 |
| CTGGAAACCG AGGCGTTCTG ATATGATTAT GGATCCTTTT GGTTTAGGGA GAATTGTTCA 600 |
| GGATGGTCTT GTGTTCCGTC AGAATTTTTC CATTAGGTCT TATGAAATAG GTGCTGATCG 660 |
| CTCTGCGTCT ATAGAAACTG TCATGAATCA TTTACAGGAA ACGGCGCTTA ATCATGTGAA 720 |
| GTCTGCCGGA CTGCTGGAAA ATGGGTTTGG GTCCACTCCT GAGATGTTTA AGAAGAATTT 780 |
| GATATGGGTC GTTGCTCGTA TGCAGGTTGT CGTTGATAAA TATCCTACTT GGGGAGATGT 840 |
| TGTGGAAGTG GATACTTGGG TTAGTCAGTC TGGAAAGAAT GGTATGCGTC GTGATTGGCT 900 |
| AGTTCGGGAT TGCAATACTG GAGAAATTGT AACGCGAGCA TCAAGTTTGT GGGTGATGAT 960 |
| GAATAAACTC ACAAGGAGAT TGTCAAAGAT TCCTGAAGAG GTTCGAGGGG AAATAGAGCC 1020 |
| TTATTTTGTG AACTCTGATC CTGTCATTGC CGAAGACAGC AGAAAGTTAA CAAAACTTGA 1080 |
| TGACAAGACT GCTGACTATG TTCGTTCTGG TCTCACTCCG AGGTGGAGTG ACTTGGATGT 1140 |
| TAACCAGCAT GTTAACAATG TAAAGTACAT TGGGTGGATA CTGGAGAGTG CTCCAGCAGG 1200 |
| GATGCTGGAG AGTCAGAAGC TGAAAAGCAT GACTCTGGAG TATCGCAGGG AGTGCGGGAG 1260 |
| AGACAGTGTG CTTCAGTCTC TCACCGCAGT CTCTGGATGT GATGTCGGTA ACCTCGGGAC 1320 |
| AGCCGGGGAA GTGGAGTGTC AGCATTTGCT TCGACTCCAG GATGGAGCTG AAGTGGTGAG 1380 |
| AGGAAGAACA GAGTGGAGCT CCAAGACAGG AGCAACAACT TGGGACACTA CTACATCGTA 1440 |
| AACATTGGTC CTTTGGTTCC TTTGTAAAAC TGTACCTGCT GCTACCTTCT TGCAACCACC 1500 |
| ACCTTTGTAT ATTTCTTCTT TTTTGTTTTT TATTTTGCTT CAATGGAGAT ATATTATTAT 1560 |
| TTATTTAATC TTTCTATTTT TTTTGTTTTC TTATGGGAAA TGGGTGTATT ATGTGATATA 1620 |
| TTATTGTAAC CCCATGTGCC AGGGCAAGGC AATAACTTTC TTATCAAAAA AAAA 1674 |
| (2) INFORMATION FOR SEQ ID NO: 32: |
| (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 415 amino acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: unknown |
| (D) TOPOLOGY: unknown |
| (ii) MOLECULE TYPE: protein |
| (iii) HYPOTHETICAL: NO |
| (vi) ORIGINAL SOURCE: |
| (A) ORGANISM: not provided |
| (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 32 |
| Met Val Ala Thr Cys Ala Thr Ser Ser Phe Phe His Val Pro Ser Ser |
| 1 5 10 15 |
| Ser Ser Leu Asp Thr Asn Gly Lys Gly Asn Arg Val Gly Ser Thr Asn |
| 20 25 30 |
| Phe Ala Gly Leu Asn Ser Thr Pro Ser Ser Gly Arg Met Lys Val Lys |
| 35 40 45 |
| Pro Asn Ala Gln Ala Pro Pro Lys Ile Asn Gly Lys Lys Ala Asn Leu |
| 50 55 60 |
| Pro Gly Ser Val Glu Ile Ser Lys Ala Asp Asn Glu Thr Ser Gln Pro |
| 65 70 75 80 |
| Ala His Ala Pro Arg Thr Phe Ile Asn Gln Leu Pro Asp Trp Ser Met |
| 85 90 95 |
| Leu Leu Ala Ala Ile Thr Thr Ile Phe Leu Ala Ala Glu Lys Gln Trp |
| 100 105 110 |
| Met Met Leu Asp Trp Lys Pro Arg Arg Ser Asp Met Ile Met Asp Pro |
| 115 120 125 |
| Phe Gly Leu Gly Arg Ile Val Gln Asp Gly Leu Val Phe Arg Gln Asn |
| 130 135 140 |
| Phe Ser Ile Arg Ser Tyr Glu Ile Gly Ala Asp Arg Ser Ala Ser Ile |
| 145 150 155 160 |
| Glu Thr Val Met Asn His Leu Gln Glu Thr Ala Leu Asn His Val Lys |
| 165 170 175 |
| Ser Ala Gly Leu Leu Glu Asn Gly Phe Gly Ser Thr Pro Glu Met Phe |
| 180 185 190 |
| Lys Lys Asn Leu Ile Trp Val Val Ala Arg Met Gln Val Val Val Asp |
| 195 200 205 |
| Lys Tyr Pro Thr Trp Gly Asp Val Val Glu Val Asp Thr Trp Val Ser |
| 210 215 220 |
| Gln Ser Gly Lys Asn Gly Met Arg Arg Asp Trp Leu Val Arg Asp Cys |
| 225 230 235 240 |
| Asn Thr Gly Glu Ile Val Thr Arg Ala Ser Ser Leu Trp Val Met Met |
| 245 250 255 |
| Asn Lys Leu Thr Arg Arg Leu Ser Lys Ile Pro Glu Glu Val Arg Gly |
| 260 265 270 |
| Glu Ile Glu Pro Tyr Phe Val Asn Ser Asp Pro Val Ile Ala Glu Asp |
| 275 280 285 |
| Ser Arg Lys Leu Thr Lys Leu Asp Asp Lys Thr Ala Asp Tyr Val Arg |
| 290 295 300 |
| Ser Gly Leu Thr Pro Arg Trp Ser Asp Leu Asp Val Asn Gln His Val |
| 305 310 315 320 |
| Asn Asn Val Lys Tyr Ile Gly Trp Ile Leu Glu Ser Ala Pro Ala Gly |
| 325 330 335 |
| Met Leu Glu Ser Gln Lys Leu Lys Ser Met Thr Leu Glu Tyr Arg Arg |
| 340 345 350 |
| Glu Cys Gly Arg Asp Ser Val Leu Gln Ser Leu Thr Ala Val Ser Gly |
| 355 360 365 |
| Cys Asp Val Gly Asn Leu Gly Thr Ala Gly Glu Val Glu Cys Gln His |
| 370 375 380 |
| Leu Leu Arg Leu Gln Asp Gly Ala Glu Val Val Arg Gly Arg Thr Glu |
| 385 390 395 400 |
| Trp Ser Ser Lys Thr Gly Ala Thr Thr Trp Asp Thr Thr Thr Ser |
| 405 410 415 |
| Patent | Priority | Assignee | Title |
| 8956834, | Jun 29 2009 | SYNTHETIC GENOMICS, INC | Acyl-ACP thioesterase genes and uses therefor |
| 9920340, | Jun 29 2009 | Synthetic Genomics, Inc. | Acyl-ACP thioesterase genes and uses therefor |
| Patent | Priority | Assignee | Title |
| 4394443, | Dec 18 1980 | YALE UNIVERSITY, | Method for cloning genes |
| 5530186, | Dec 20 1990 | E I DU PONT DE NEMOURS AND COMPANY | Nucleotide sequences of soybean acyl-ACP thioesterase genes |
| 5723761, | Nov 10 1993 | Monsanto Company | Plant acyl-ACP thioesterase sequences |
| EP255378, | |||
| EP301749, | |||
| WO9116421, | |||
| WO9211373, | |||
| WO9220236, | |||
| WO9410288, | |||
| WO9506740, | |||
| WO9513390, | |||
| WO9012084, | |||
| WO9116421, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Mar 24 2000 | E. I. du Pont de Nemours and Company | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Dec 25 2002 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
| Feb 26 2007 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
| Feb 22 2011 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
| Date | Maintenance Schedule |
| Aug 07 2004 | 4 years fee payment window open |
| Feb 07 2005 | 6 months grace period start (w surcharge) |
| Aug 07 2005 | patent expiry (for year 4) |
| Aug 07 2007 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Aug 07 2008 | 8 years fee payment window open |
| Feb 07 2009 | 6 months grace period start (w surcharge) |
| Aug 07 2009 | patent expiry (for year 8) |
| Aug 07 2011 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Aug 07 2012 | 12 years fee payment window open |
| Feb 07 2013 | 6 months grace period start (w surcharge) |
| Aug 07 2013 | patent expiry (for year 12) |
| Aug 07 2015 | 2 years to revive unintentionally abandoned end. (for year 12) |